<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/chrp/rss"/>
    <ttl>720</ttl>
    <title>Recent chrp items</title>
    <link>https://escholarship.org/uc/chrp/rss</link>
    <description>Recent eScholarship items from California HIV/AIDS Research Program</description>
    <pubDate>Thu, 3 Sep 2026 04:08:49 +0000</pubDate>
    <item>
      <title>Randomized Controlled Trial Testing an HIV/STI Prevention Intervention Among People Leaving Incarceration Who Were Assigned Male at Birth, Have Sex with Men and A Substance Use Disorder</title>
      <link>https://escholarship.org/uc/item/70p4g7ng</link>
      <description>HIV disproportionately impacts minoritized individuals, particularly those of intersectional minoritized identities. Incarceration disproportionately impacts minoritized individuals as well, and increases HIV risk, in part due to its disruption to people’s lives, social networks, and access to care. We developed MEPS, a 6-month intervention designed to holistically support HIV prevention in men who have sex with men and transgender women leaving incarceration. We tested MEPS in a 1:1 randomized controlled trial with 208 individuals. All participants received a needs assessment and personalized wellness plan, followed by either standard of care or the MEPS intervention. MEPS integrated support from a Peer Mentor, incentives for engagement in social and health services, and a mobile app. Participants completed baseline assessments and follow-up assessments at 3, 6, and 9 months. We tested for changes in PrEP use using a group-based trajectory model, for changes in HIV and STI testing,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/70p4g7ng</guid>
      <pubDate>Wed, 30 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Schrode, Katrina M</name>
      </author>
      <author>
        <name>Edwards, Gabriel G</name>
        <uri>https://orcid.org/0000-0002-1083-0919</uri>
      </author>
      <author>
        <name>Moghanian, Brandon</name>
      </author>
      <author>
        <name>Weiss, Robert E</name>
        <uri>https://orcid.org/0000-0003-3648-8522</uri>
      </author>
      <author>
        <name>Reback, Cathy J</name>
      </author>
      <author>
        <name>McWells, Charles</name>
      </author>
      <author>
        <name>Hilliard, Charles L</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San Francisco</title>
      <link>https://escholarship.org/uc/item/70j4z6f2</link>
      <description>BackgroundPoint-of-care HIV viral load testing may enhance patient care and improve HIV health services. We aimed to evaluate the feasibility and acceptability of implementing such testing in a high-volume community sexual health clinic in the United States.MethodsWe conducted a cross-sectional, mixed-methods study. Remnant venipuncture specimens from clients undergoing HIV and other sexual health screenings were analyzed using the Xpert® HIV-1 Viral Load assay. Results were compared to COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test. Clinical staff observations, study meeting notes, and two semi-structured in-depth interviews with clinical staff were used to understand perspectives on incorporating this testing into clinical practice.ResultsWe analyzed 113 samples from 111 clients. The Xpert assay showed excellent agreement with COBAS, with no clinically significant difference in viral load measurements. Clinical staff found Xpert testing acceptable, based on its ability to provide...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/70j4z6f2</guid>
      <pubDate>Tue, 1 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Moore Jr., Kelvin</name>
      </author>
      <author>
        <name>Tourneau, Noelle Le</name>
      </author>
      <author>
        <name>Alvarez, Jasmin</name>
      </author>
      <author>
        <name>Rodriguez, Santos</name>
      </author>
      <author>
        <name>Broussard, Janessa</name>
      </author>
      <author>
        <name>Crouch, Pierre-Cédric</name>
      </author>
      <author>
        <name>Roman, Jorge</name>
      </author>
      <author>
        <name>Defechereux, Patricia</name>
      </author>
      <author>
        <name>Bena, Jason</name>
      </author>
      <author>
        <name>Koester, Kimberly A</name>
      </author>
      <author>
        <name>Moran, Lissa</name>
      </author>
      <author>
        <name>Pilcher, Christopher</name>
      </author>
      <author>
        <name>Grant, Robert</name>
      </author>
      <author>
        <name>Christopoulos, Katerina A</name>
      </author>
    </item>
    <item>
      <title>Strategies to Facilitate Service Utilization Among Youth at Risk for HIV: A Randomized Controlled Trial (ATN 149)</title>
      <link>https://escholarship.org/uc/item/1cj8t25t</link>
      <description>Sexual and gender minority youth (SGMY) are vulnerable to acquiring HIV and need HIV prevention and health services, but may have competing needs. A prior analysis found that PrEP use reports increased in a combination intervention study arm with coaching, peer support, and automated text-messages. This paper examines ancillary support and healthcare services utilization as secondary intervention objectives. SGMY (N = 895, 40% Black, 29% Latino) in Los Angeles and New Orleans were recruited from May, 2017 to August, 2019 and randomized to four intervention conditions: (a) automated text-messaging and monitoring intervention (AMMI), (b) AMMI plus peer support online (AMMI+PS), (c) AMMI plus strengths-based coaching by near-peer paraprofessionals (AMMI+C), or (d) all three (AMMI+PS+C). Intent-to-treat multivariate regression analyses evaluated the interventions' efficacy on past 4-month reports of ancillary support services use, having a regular healthcare provider, receiving care...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1cj8t25t</guid>
      <pubDate>Thu, 27 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Swendeman, Dallas</name>
        <uri>https://orcid.org/0000-0002-4570-6352</uri>
      </author>
      <author>
        <name>Rotheram-Borus, Mary Jane</name>
      </author>
      <author>
        <name>Arnold, Elizabeth Mayfield</name>
      </author>
      <author>
        <name>Fernández, Maria Isabel</name>
      </author>
      <author>
        <name>Comulada, W Scott</name>
      </author>
      <author>
        <name>Ishimoto, Kelsey</name>
      </author>
      <author>
        <name>Gertsch, William</name>
      </author>
      <author>
        <name>Murphy, Debra A</name>
      </author>
      <author>
        <name>Ocasio, Manuel</name>
      </author>
      <author>
        <name>Lee, Sung-Jae</name>
        <uri>https://orcid.org/0000-0002-7924-7430</uri>
      </author>
      <author>
        <name>Lewis, Katherine A</name>
      </author>
    </item>
    <item>
      <title>Strategies to Facilitate Service Utilization Among Youth at Risk for HIV: A Randomized Controlled Trial (ATN 149)</title>
      <link>https://escholarship.org/uc/item/7sv549n3</link>
      <description>Sexual and gender minority youth (SGMY) are vulnerable to acquiring HIV and need HIV prevention and health services, but may have competing needs. A prior analysis found that PrEP use reports increased in a combination intervention study arm with coaching, peer support, and automated text-messages. This paper examines ancillary support and healthcare services utilization as secondary intervention objectives. SGMY (N = 895, 40% Black, 29% Latino) in Los Angeles and New Orleans were recruited from May, 2017 to August, 2019 and randomized to four intervention conditions: (a) automated text-messaging and monitoring intervention (AMMI), (b) AMMI plus peer support online (AMMI+PS), (c) AMMI plus strengths-based coaching by near-peer paraprofessionals (AMMI+C), or (d) all three (AMMI+PS+C). Intent-to-treat multivariate regression analyses evaluated the interventions’ efficacy on past 4-month reports of ancillary support services use, having a regular healthcare provider, receiving care...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7sv549n3</guid>
      <pubDate>Tue, 25 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Swendeman, Dallas</name>
        <uri>https://orcid.org/0000-0002-4570-6352</uri>
      </author>
      <author>
        <name>Rotheram-Borus, Mary Jane</name>
      </author>
      <author>
        <name>Arnold, Elizabeth Mayfield</name>
      </author>
      <author>
        <name>Fernández, Maria Isabel</name>
      </author>
      <author>
        <name>Comulada, W Scott</name>
      </author>
      <author>
        <name>Ishimoto, Kelsey</name>
      </author>
      <author>
        <name>Gertsch, William</name>
      </author>
      <author>
        <name>Murphy, Debra A</name>
      </author>
      <author>
        <name>Ocasio, Manuel</name>
      </author>
      <author>
        <name>Lee, Sung-Jae</name>
        <uri>https://orcid.org/0000-0002-7924-7430</uri>
      </author>
      <author>
        <name>Lewis, Katherine A</name>
      </author>
    </item>
    <item>
      <title>Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire</title>
      <link>https://escholarship.org/uc/item/3mt667h7</link>
      <description>Combining a T cell-targeting mRNA vaccine encoding the conserved SARS-CoV-2 RNA-dependent RNA polymerase, RdRp, with a Spike-encoding mRNA vaccine may offer an additional pathway toward COVID-19 protection. Here, we show that a nucleoside-modified RdRp mRNA vaccine raises robust and durable CD8+ T cell responses in mice. Immunization drives a CD8+ T cell response enriched toward a specific RdRp epitope. Unexpectedly, coadministration of mRNA vaccines encoding RdRp or the Spike Receptor Binding Domain (RBD) dampens RBD-specific immune responses. Contralateral administration reduces the suppression of RBD-specific T cell responses while type I interferon signaling blockade restores RBD-specific antibodies. A staggered immunization strategy maintains both RBD vaccine-mediated antibody and T cell responses as well as protection against lethal SARS-CoV-2 challenge in human ACE2 transgenic mice. In HLA-A2.1 transgenic mice, the RdRp vaccine elicits CD8+ T cell responses against HLA-A*02:01-restricted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3mt667h7</guid>
      <pubDate>Thu, 26 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Abt, Evan R</name>
      </author>
      <author>
        <name>Lam, Alex K</name>
      </author>
      <author>
        <name>Noguchi, Miyako</name>
      </author>
      <author>
        <name>Rashid, Khalid</name>
      </author>
      <author>
        <name>McLaughlin, Jami</name>
      </author>
      <author>
        <name>Teng, Pu-Lin</name>
      </author>
      <author>
        <name>Tran, Wendy</name>
      </author>
      <author>
        <name>Cheng, Donghui</name>
      </author>
      <author>
        <name>Nesterenko, Pavlo A</name>
      </author>
      <author>
        <name>Mao, Zhiyuan</name>
      </author>
      <author>
        <name>Creech, Amanda L</name>
      </author>
      <author>
        <name>Sojo, Giselle Burton</name>
      </author>
      <author>
        <name>Jeyachandran, Arjit Vijey</name>
      </author>
      <author>
        <name>Tam, Ying K</name>
      </author>
      <author>
        <name>Henley, Jill E</name>
      </author>
      <author>
        <name>Comai, Lucio</name>
      </author>
      <author>
        <name>Pardi, Norbert</name>
      </author>
      <author>
        <name>Arumugaswami, Vaithilingaraja</name>
      </author>
      <author>
        <name>Witte, Owen N</name>
        <uri>https://orcid.org/0000-0003-4461-4533</uri>
      </author>
      <author>
        <name>Radu, Caius G</name>
        <uri>https://orcid.org/0000-0002-9338-5397</uri>
      </author>
      <author>
        <name>Wu, Ting-Ting</name>
      </author>
    </item>
    <item>
      <title>Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies</title>
      <link>https://escholarship.org/uc/item/9j09602b</link>
      <description>BACKGROUND: Oral pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (F/TDF) has high efficacy against HIV-1 acquisition. Seventy-two prospective studies of daily oral F/TDF PrEP were conducted to evaluate HIV-1 incidence, drug resistance, adherence, and bone and renal safety in diverse settings.
METHODS: HIV-1 incidence was calculated from incident HIV-1 diagnoses after PrEP initiation and within 60 days of discontinuation. Tenofovir concentrations in dried blood spots (DBS), drug resistance, and bone/renal safety indicators were evaluated in a subset of studies.
RESULTS: Among 17 274 participants, there were 101 cases with new HIV-1 diagnosis (.77 per 100 person-years; 95% confidence interval [CI]: .63-.94). In 78 cases with resistance data, 18 (23%) had M184I or V, 1 (1.3%) had K65R, and 3 (3.8%) had both mutations. In 54 cases with tenofovir concentration data from DBS, 45 (83.3%), 2 (3.7%), 6 (11.1%), and 1 (1.9%) had average adherence of &amp;lt;2,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9j09602b</guid>
      <pubDate>Sat, 23 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
      <author>
        <name>Tao, Li</name>
      </author>
      <author>
        <name>Yang, Juan</name>
      </author>
      <author>
        <name>de Boer, Melanie</name>
      </author>
      <author>
        <name>Carter, Christoph</name>
      </author>
      <author>
        <name>Das, Moupali</name>
      </author>
      <author>
        <name>Baeten, Jared M</name>
      </author>
      <author>
        <name>Liu, Albert</name>
      </author>
      <author>
        <name>Hoover, Karen W</name>
      </author>
      <author>
        <name>Celum, Connie</name>
      </author>
      <author>
        <name>Grinsztejn, Beatriz</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Wheeler, Darrell P</name>
      </author>
      <author>
        <name>Mayer, Kenneth H</name>
      </author>
      <author>
        <name>Golub, Sarit A</name>
      </author>
      <author>
        <name>Bekker, Linda-Gail</name>
      </author>
      <author>
        <name>Diabaté, Souleymane</name>
      </author>
      <author>
        <name>Hoornenborg, Elske</name>
      </author>
      <author>
        <name>Myers, Janet</name>
      </author>
      <author>
        <name>Leech, Ashley A</name>
      </author>
      <author>
        <name>McCormack, Sheena</name>
      </author>
      <author>
        <name>Chan, Philip A</name>
      </author>
      <author>
        <name>Sweat, Michael</name>
      </author>
      <author>
        <name>Matthews, Lynn T</name>
      </author>
      <author>
        <name>Grant, Robert</name>
      </author>
      <author>
        <name>Beyrer, Chris</name>
      </author>
      <author>
        <name>Brown, Joelle</name>
      </author>
      <author>
        <name>Clark, Jesse</name>
        <uri>https://orcid.org/0000-0001-5862-6530</uri>
      </author>
      <author>
        <name>Colson, Paul</name>
      </author>
      <author>
        <name>Eakle, Robyn</name>
      </author>
      <author>
        <name>Farley, Jason</name>
      </author>
      <author>
        <name>Flash, Charlene A</name>
      </author>
      <author>
        <name>Gallardo, Jorge</name>
      </author>
      <author>
        <name>Gottlieb, Geoffrey</name>
      </author>
      <author>
        <name>Grangeiro, Alexandre</name>
      </author>
      <author>
        <name>Heffron, Renee</name>
      </author>
      <author>
        <name>Hosek, Sybil</name>
      </author>
      <author>
        <name>Hull, Mark</name>
      </author>
      <author>
        <name>Idoko, John</name>
      </author>
      <author>
        <name>Inwani, Irene</name>
      </author>
      <author>
        <name>Koenig, Helen</name>
      </author>
      <author>
        <name>Kurth, Ann</name>
      </author>
      <author>
        <name>Lee, Shui-shan</name>
      </author>
      <author>
        <name>Mayer, Kenneth</name>
      </author>
      <author>
        <name>Mboup, Souleymane</name>
      </author>
      <author>
        <name>Meyer, Jaimie</name>
      </author>
      <author>
        <name>Mills, Anthony</name>
      </author>
      <author>
        <name>Mujugira, Andrew</name>
      </author>
      <author>
        <name>Pala, Pietro</name>
      </author>
      <author>
        <name>Phoenix, John</name>
      </author>
      <author>
        <name>Piatt, Janice</name>
      </author>
      <author>
        <name>Russell, Darren</name>
      </author>
      <author>
        <name>Sanders, Eduard</name>
      </author>
      <author>
        <name>Scott, Rachel</name>
      </author>
      <author>
        <name>Sevelius, Jae</name>
      </author>
      <author>
        <name>Shang, Hong</name>
      </author>
      <author>
        <name>Siegel, Marc</name>
      </author>
      <author>
        <name>Swaminathan, Shobha</name>
      </author>
      <author>
        <name>Tamayo, Vivian</name>
      </author>
      <author>
        <name>Tan, Darrell</name>
      </author>
      <author>
        <name>Taylor, Allan</name>
      </author>
      <author>
        <name>Vuylsteke, Bea</name>
      </author>
    </item>
    <item>
      <title>A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California</title>
      <link>https://escholarship.org/uc/item/84w4m8cp</link>
      <description>BACKGROUND: Pre-exposure prophylaxis (PrEP) uptake remains low among people who could benefit, some of whom may prefer alternatives to oral PrEP, such as long-acting injectable pre-exposure prophylaxis (LAI-PrEP). We evaluated the potential for LAI-PrEP provision in pharmacies through a mixed methods study of pharmacists in California, where Senate Bill 159 enables pharmacists to independently provide oral PrEP.
METHODS: In 2022-2023, we conducted an online cross-sectional survey of California pharmacists and pharmacy students (n = 919) and in-depth interviews with pharmacists (n = 30), both of which included modules assessing attitudes about PrEP provision. Using log-binomial regression, we estimated prevalence ratios (PRs) comparing survey participants' willingness to provide LAI-PrEP by pharmacy- and individual-level characteristics. Qualitative interview data were analyzed using Rapid Qualitative Analysis to identify factors that may affect pharmacists' provision of LAI-PrEP.
RESULTS:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/84w4m8cp</guid>
      <pubDate>Mon, 18 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Beltran, Raiza M</name>
      </author>
      <author>
        <name>Hunter, Lauren A</name>
      </author>
      <author>
        <name>Packel, Laura J</name>
      </author>
      <author>
        <name>De Martini, Loriann</name>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Dong, Betty J</name>
      </author>
      <author>
        <name>Lam, Jerika</name>
      </author>
      <author>
        <name>McCoy, Sandra I</name>
      </author>
      <author>
        <name>Ochoa, Ayako Miyashita</name>
      </author>
    </item>
    <item>
      <title>WOULD THE SIBLINGS OF LATINX MEN WHO HAVE SEX WITH MEN ENCOURAGE THEIR BROTHERS TO USE PrEP? FINDINGS FROM A FEASIBILITY AND ACCEPTABILITY STUDY</title>
      <link>https://escholarship.org/uc/item/23j754b7</link>
      <description>We explored whether siblings can be engaged in PrEP promotion. We used the Information-Motivation-Behavior model to develop and conduct surveys and dyadic interviews with Latino men who have sex with men (LMSM) and their siblings (n = 31) and three sibling-only focus groups (n = 20). For LMSM, only n = 14 (45%) agreed they would benefit from taking PrEP, yet &lt;i&gt;n&lt;/i&gt; = 22 (71%) would take PrEP to make their sibling worry less about them, and &lt;i&gt;n&lt;/i&gt; = 23 (74%) requested a PrEP referral. For siblings, n = 20 (65%) believed PrEP would benefit their brother, and n = 19 (95%) in the focus groups said they would take PrEP to help their brother get started. Qualitative results include (1) siblings' support for PrEP use, (2) explicit conversations about sex were not necessary for discussing sexual health, and (3) siblings wanted to understand what they could do to encourage their brother to consider PrEP. We conclude siblings can be engaged in PrEP promotion.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/23j754b7</guid>
      <pubDate>Sat, 6 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Del Pino, Homero E</name>
      </author>
      <author>
        <name>Rojas, Edwin</name>
      </author>
      <author>
        <name>Dācus, Jagadīśa-Devaśrī</name>
      </author>
      <author>
        <name>Durán, Petra</name>
      </author>
      <author>
        <name>Martínez, Angel J</name>
      </author>
      <author>
        <name>Hernández, José A</name>
      </author>
      <author>
        <name>Ayala, George</name>
      </author>
      <author>
        <name>Zea, María-Cecilia</name>
      </author>
      <author>
        <name>Schrode, Katrina</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV</title>
      <link>https://escholarship.org/uc/item/4mg4p88n</link>
      <description>BackgroundCisgender women account for 1 in 5 new HIV infections in the United States, yet remain under-engaged in HIV prevention. Women experiencing violence face risk for HIV due to biological and behavioral mechanisms, and barriers to prevention, such as challenges to Pre-Exposure Prophylaxis for HIV Prevention (PrEP) adherence. In this analysis, we aim to characterize intimate partner violence (IPV) among cisgender heterosexual women enrolled in a PrEP demonstration project and assess the associations with PrEP adherence.MethodsAdherence Enhancement Guided by Individualized Texting and Drug Levels (AEGiS) was a 48-week single-arm open-label study of PrEP adherence in HIV-negative cisgender women in Southern California (N = 130) offered daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC). From 6/2016 to 10/2018, women completed a survey reporting HIV risk behavior and experiences of any IPV (past 90-days) and IPV sub-types (past-year, lifetime) and biological testing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4mg4p88n</guid>
      <pubDate>Mon, 17 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Anderson, Katherine M</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Jain, Sonia</name>
      </author>
      <author>
        <name>Sun, Xiaoying</name>
      </author>
      <author>
        <name>Amico, K Rivet</name>
      </author>
      <author>
        <name>Landovitz, Raphael</name>
      </author>
      <author>
        <name>Zachek, Christine M</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Stockman, Jamila K</name>
      </author>
    </item>
    <item>
      <title>Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation</title>
      <link>https://escholarship.org/uc/item/7pf8n18q</link>
      <description>Host-directed therapy (HDT) is an emerging approach to overcome antimicrobial resistance in pathogenic microorganisms. Specifically, HDT targets host-encoded factors required for pathogen replication and survival without interfering with microbial growth or metabolism, thereby eliminating the risk of resistance development. By applying HDT and a drug repurposing approach, we demonstrate that (&lt;i&gt;R&lt;/i&gt;)-DI-87, a clinical-stage anti-cancer drug and potent inhibitor of mammalian deoxycytidine kinase (dCK), mitigates &lt;i&gt;Staphylococcus aureus&lt;/i&gt; abscess formation in organ tissues upon invasive bloodstream infection. Mechanistically, (&lt;i&gt;R&lt;/i&gt;)-DI-87 shields phagocytes from staphylococcal death-effector deoxyribonucleosides that target dCK and the mammalian purine salvage pathway-apoptosis axis. In this manner, (&lt;i&gt;R&lt;/i&gt;)-DI-87-mediated protection of immune cells amplifies macrophage infiltration into deep-seated abscesses, a phenomenon coupled with enhanced pathogen control, ameliorated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7pf8n18q</guid>
      <pubDate>Fri, 12 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Winstel, Volker</name>
      </author>
      <author>
        <name>Abt, Evan R</name>
      </author>
      <author>
        <name>Le, Thuc M</name>
      </author>
      <author>
        <name>Radu, Caius G</name>
        <uri>https://orcid.org/0000-0002-9338-5397</uri>
      </author>
    </item>
    <item>
      <title>Tailoring a mobile health text-messaging intervention to promote antiretroviral therapy adherence among African Americans: A qualitative study</title>
      <link>https://escholarship.org/uc/item/0xw6k3h7</link>
      <description>African Americans are disproportionately affected by HIV and socio-structural barriers that impact antiretroviral (ART) adherence. Two-way text-messaging interventions have shown promise in supporting adherence in US studies of mostly White people living with HIV (PLWH). However, culturally-appropriate tailoring is necessary to maximize intervention effectiveness among other racial/ethnic groups. Thus, to refine an existing text-messaging intervention, we examined barriers and facilitators to ART adherence among African Americans and perspectives on features to integrate into the extant intervention. Three focus groups, two with African American PLWH (n = 5 and n = 7) and one with providers of care (n = 11) were conducted; transcripts of audio-recordings were thematically analyzed. Adherence supports operated at individual, interpersonal, and structural/environmental levels (e.g., using reminders and pill organizers, wanting to protect partners from HIV, and positive interactions...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0xw6k3h7</guid>
      <pubDate>Mon, 8 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Pasipanodya, Elizabeth C</name>
      </author>
      <author>
        <name>Montoya, Jessica L</name>
      </author>
      <author>
        <name>Watson, Caitlin W-M</name>
      </author>
      <author>
        <name>Marquine, María J</name>
      </author>
      <author>
        <name>Hoenigl, Martin</name>
        <uri>https://orcid.org/0000-0002-1653-2824</uri>
      </author>
      <author>
        <name>Garcia, Rogelio</name>
      </author>
      <author>
        <name>Kua, John</name>
      </author>
      <author>
        <name>Gant, Verna</name>
      </author>
      <author>
        <name>Trambley, Joel</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
    </item>
    <item>
      <title>Socio-Structural and Neighborhood Predictors of Incident Criminal Justice Involvement in a Population-Based Cohort of Young Black MSM and Transgender Women</title>
      <link>https://escholarship.org/uc/item/18f4s3h6</link>
      <description>Black men who have sex with men (MSM) and transgender women are disproportionately affected by criminal justice involvement (CJI) and HIV. This study recruited 618 young Black MSM and transgender women in Chicago, IL, using respondent-driven sampling between 2013 and 2014. Random effects logistic regression evaluated predictors of incident CJI over 18&amp;nbsp;months of follow-up. Controlling for respondent age, gender and sexual identity, spirituality (aOR 0.56, 95% CI 0.33–0.96), and presence of a mother figure (aOR 0.41, 95% CI 0.19–0.89) were protective against CJI. Economic hardship (financial or residential instability vs. neither aOR 2.23, 95% CI 1.10–4.51), two or more past episodes of CJI vs. none (aOR 2.66, 95% CI 1.40–5.66), and substance use (marijuana use vs. none aOR 2.79, 95% CI 1.23–6.34; other drug use vs. none aOR 4.49, 95% CI 1.66–12.16) were associated with CJI during follow-up. Research to identify and leverage resilience factors that can buffer the effects of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/18f4s3h6</guid>
      <pubDate>Sun, 7 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hotton, Anna L</name>
      </author>
      <author>
        <name>Chen, Yen-Tyng</name>
      </author>
      <author>
        <name>Schumm, Phil</name>
      </author>
      <author>
        <name>Khanna, Aditya S</name>
      </author>
      <author>
        <name>Brewer, Russell</name>
      </author>
      <author>
        <name>Skaathun, Britt</name>
      </author>
      <author>
        <name>Issema, Rodal S</name>
      </author>
      <author>
        <name>Ramani, Santhoshini</name>
      </author>
      <author>
        <name>Ramachandran, Arthi</name>
      </author>
      <author>
        <name>Ozik, Jonathan</name>
      </author>
      <author>
        <name>Fujimoto, Kayo</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Schneider, John A</name>
      </author>
    </item>
    <item>
      <title>The associations between HIV stigma and mental health symptoms, life satisfaction, and quality of life among Black sexual minority men with HIV</title>
      <link>https://escholarship.org/uc/item/34v0w9v6</link>
      <description>PurposeWith the advancement of antiretroviral therapy (ART), HIV/AIDS has become a manageable illness, similar to other chronic conditions. This study examined the associations between HIV stigma and patient-reported outcomes including mental health symptoms, life satisfaction, and quality of life among Black sexual minority men with HIV.MethodsWe analyzed baseline data from a randomized comparison trial of a mobile app intervention aimed to address the social work and legal needs of Black sexual minority men with HIV in Los Angeles County. We used validated scales including the Berger HIV stigma scale, the Patient Health Questionnaire-9 &amp;amp; the General Anxiety Disorder-7, the Satisfaction with Life Scale, and the Ladder Scale to assess HIV stigma, depressive symptoms, anxiety, life satisfaction, and quality of life, and we conducted multivariable linear regression to examine their associations.ResultsParticipants experienced HIV stigma especially about disclosure concerns (e.g.,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/34v0w9v6</guid>
      <pubDate>Wed, 3 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hong, Chenglin</name>
      </author>
      <author>
        <name>Ochoa, Ayako Miyashita</name>
      </author>
      <author>
        <name>Wilson, Bianca DM</name>
        <uri>https://orcid.org/0000-0001-5842-5229</uri>
      </author>
      <author>
        <name>Wu, Elizabeth SC</name>
      </author>
      <author>
        <name>Thomas, Damone</name>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
    </item>
    <item>
      <title>Determinants of HIV Pre-Exposure Prophylaxis (PrEP) Retention among Transgender Women: A Sequential, Explanatory Mixed Methods Study</title>
      <link>https://escholarship.org/uc/item/8tn2204p</link>
      <description>Transgender women (TW) face inequities in HIV and unique barriers to PrEP, an effective biomedical intervention to prevent HIV acquisition. To improve PrEP retention among TW, we examined factors related to retention using a two-phase, sequential explanatory mixed methods approach. In Phase I, we used data from a trial of 170 TW who were provided oral PrEP to examine predictors of 24-week retention. In Phase II, we conducted 15 in-depth interviews with PrEP-experienced TW and used thematic analysis to explain Phase I findings. In Phase I, more participants who were not retained at 24 weeks reported sex work engagement (18% versus 7%) and substantial/severe drug use (18% versus 8%). In Phase II, participants reported drug use as a barrier to PrEP, often in the context of sex work, and we identified two subcategories of sex work. TW engaged in "non-survival sex work" had little difficulty staying on PrEP, while those engaged in "survival sex work" struggled to stay on PrEP. In Phase...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8tn2204p</guid>
      <pubDate>Fri, 1 Mar 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Andrzejewski, Jack</name>
        <uri>https://orcid.org/0000-0002-3109-9774</uri>
      </author>
      <author>
        <name>Pines, Heather A</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Burke, Leah</name>
        <uri>https://orcid.org/0000-0001-8220-3263</uri>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Sevelius, Jae</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
    </item>
    <item>
      <title>Harnessing Digital Data and Data Science to Achieve 90-90-90 Goals to End the HIV Epidemic</title>
      <link>https://escholarship.org/uc/item/7qx6p2sc</link>
      <description>PURPOSE OF REVIEW: Effective public health interventions depend on timely, accurate surveillance. Harnessing digital data (including internet searches, social media, and online media) and data science is an emerging approach to complement traditional surveillance in public health but has been underutilized in HIV prevention and treatment.
RECENT FINDINGS: We highlight recent examples that illustrate how social media data can be applied to HIV surveillance and prevention interventions.
SUMMARY: To achieve 90-90-90 goals to end the HIV epidemic, we encourage traditional public health researchers to partner with data scientists to supplement HIV surveillance programs with social media analytics to refine estimates of HIV infections and key populations at risk and to identify subgroups and regions where prevention and treatment efforts need to be bolstered. We also encourage interdisciplinary teams to design interventions to promote HIV prevention and linkage to care by leveraging...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7qx6p2sc</guid>
      <pubDate>Sun, 25 Feb 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Strathdee, Steffanie A</name>
      </author>
      <author>
        <name>Nobles, Alicia Lynn</name>
      </author>
      <author>
        <name>Ayers, John W</name>
      </author>
    </item>
    <item>
      <title>Characteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners</title>
      <link>https://escholarship.org/uc/item/5t17x8kx</link>
      <description>Transgender people continue to be at high-risk for HIV acquisition, but little is known about the characteristics of their sexual partners. To address this gap, we examined sociodemographic and sexual characteristics of cisgender men who have sex with men (MSM) on pre-exposure prophylaxis (PrEP) reporting transgender sexual partners.A cohort of 392 MSM in southern California in a randomized clinical trial for PrEP adherence were followed from 2013 to 2016. Multivariable generalized estimating equation and logistic models identified characteristics of MSM reporting transgender sexual partners and PrEP adherence.Only 14 (4%) MSM reported having transgender sexual partners. MSM were more likely to report transgender partners if they were African American, had incident chlamydia, reported injection drug-using sexual partners, or received items for sex. Most associations remained significant in the multivariable model: African American (adjusted odds ratio [AOR] 11.20, P = .01), incident...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5t17x8kx</guid>
      <pubDate>Sun, 25 Feb 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hassan, Adiba</name>
      </author>
      <author>
        <name>Wertheim, Joel O</name>
      </author>
      <author>
        <name>Blumenthal, Jill S</name>
      </author>
      <author>
        <name>Ellorin, Eric</name>
      </author>
      <author>
        <name>Dube, Michael P</name>
      </author>
      <author>
        <name>Corado, Katya</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Morris, Sheldon R</name>
      </author>
    </item>
    <item>
      <title>#HIV: Alignment of HIV-Related Visual Content on Instagram with Public Health Priorities in the US</title>
      <link>https://escholarship.org/uc/item/47w070cq</link>
      <description>Instagram, with more than 1 billion monthly users, is the go-to social media platform to chronicle one’s life via images, but how are people using the platform to present visual content about HIV? We analyzed public Instagram posts containing the hashtag “#HIV” (because they are self-tagged as related to HIV) between January 2017 and July 2018. We described the prevalence of co-occurring hashtags and explored thematic concepts in the images using automated image recognition and topic modeling. Twenty-eight percent of all #HIV posts included hashtags focused on awareness, followed by LGBTQ (24.5%) and living with HIV (17.9%). However, specific strategies were rarely cited, including testing (10.8%), treatment (10.3%), PrEP (6.2%) and condoms (4.1%). Image analyses revealed 44.5% of posts included infographics followed by people (21.3%) thereby humanizing HIV and stigmatized populations and promoting community mobilization. Novel content such as the handwriting image-theme (3.8%)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/47w070cq</guid>
      <pubDate>Sun, 25 Feb 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Nobles, Alicia L</name>
      </author>
      <author>
        <name>Leas, Eric C</name>
      </author>
      <author>
        <name>Latkin, Carl A</name>
      </author>
      <author>
        <name>Dredze, Mark</name>
      </author>
      <author>
        <name>Strathdee, Steffanie A</name>
      </author>
      <author>
        <name>Ayers, John W</name>
      </author>
    </item>
    <item>
      <title>Efficacy of Daily Text Messaging to Support Adherence to HIV Pre-Exposure Prophylaxis (PrEP) among Stimulant-Using Men Who Have Sex with Men</title>
      <link>https://escholarship.org/uc/item/6xf8b7r8</link>
      <description>&lt;i&gt;Background&lt;/i&gt;: Men who have sex with men (MSM) who use stimulants are at increased risk for HIV infection. Adherence to pre-exposure prophylaxis (PrEP) reduces the risk of HIV infection. We evaluated the efficacy of the individualized Texting for Adherence Building (iTAB) intervention for PrEP adherence compared to standard of care (SoC) among 119 MSM who use stimulants (cocaine, methamphetamine and/or other amphetamine) from the California Collaborative Treatment Group 595 randomized control trial.&lt;i&gt;Method&lt;/i&gt;: Three ordered levels of PrEP adherence (non-adherence, adequate adherence, and near-perfect adherence) were compared between intervention arms across study visits (weeks 12 and 48) using ordinal logistic regressions.&lt;i&gt;Results&lt;/i&gt;: The effect of intervention arm was not significant in the final model; however, there was a 38% decrease in odds (OR = 0.62, &lt;i&gt;p&lt;/i&gt;=.023) of having near-perfect adherence (versus non-adherence or adequate adherence) at week 48 compared...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6xf8b7r8</guid>
      <pubDate>Wed, 24 Jan 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Serrano, Vanessa B</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Tang, Bin</name>
      </author>
      <author>
        <name>Liao, Antony</name>
      </author>
      <author>
        <name>Hoenigl, Martin</name>
      </author>
      <author>
        <name>Montoya, Jessica L</name>
      </author>
    </item>
    <item>
      <title>A learning health system approach to COVID‐19 exposure notification system rollout</title>
      <link>https://escholarship.org/uc/item/19q004qp</link>
      <description>Introduction: Digital exposure notification (EN) approaches may offer considerable advantages over traditional contact tracing in speed, scale, efficacy, and confidentiality in pandemic control. We applied the science of learning health systems to test the effect of framing and digital means, email vs Short Message Service (SMS), on EN adoption among patients of an academic health center.
Methods: We tested three communication approaches of the Apple and Google EN system in a rapid learning cycle involving 15 000 patients pseudorandomly assigned to three groups. The patients in the first group received a 284-word email that presented EN as a tool that can help slow the spread. The patients in the second group received a 32-word SMS that described EN as a new tool to help slow the spread (SlowTheSpreadSMS). Patients in the third group received a 47-word SMS that depicted the system as a new digital tool that can empower them to protect their family and friends (EmpowerSMS). A brief...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/19q004qp</guid>
      <pubDate>Fri, 8 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Tai‐Seale, Ming</name>
      </author>
      <author>
        <name>May, Nicole</name>
      </author>
      <author>
        <name>Sitapati, Amy</name>
      </author>
      <author>
        <name>Longhurst, Christopher A</name>
      </author>
    </item>
    <item>
      <title>Impact of post-incarceration care engagement interventions on HIV transmission among young Black men who have sex with men and their sexual partners: an agent-based network modeling study</title>
      <link>https://escholarship.org/uc/item/9b786331</link>
      <description>Background: Understanding the impact of incarceration on HIV transmission among Black men who have sex with men is important given their disproportionate representation among people experiencing incarceration and the potential impact of incarceration on social and sexual networks, employment, housing, and medical care. We developed an agent-based network model (ABNM) of 10,000 agents representing young Black men who have sex with men in the city of Chicago to examine the impact of varying degrees of post-incarceration care disruption and care engagement interventions following release from jail on HIV incidence.
Methods: Exponential random graph models were used to model network formation and dissolution dynamics, and network dynamics and HIV care continuum engagement were varied according to incarceration status. Hypothetical interventions to improve post-release engagement in HIV care for individuals with incarceration (e.g., enhanced case management, linkage to housing and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9b786331</guid>
      <pubDate>Wed, 6 Dec 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Hotton, Anna L</name>
      </author>
      <author>
        <name>Lee, Francis</name>
      </author>
      <author>
        <name>Sheeler, Daniel</name>
      </author>
      <author>
        <name>Ozik, Jonathan</name>
      </author>
      <author>
        <name>Collier, Nicholson</name>
      </author>
      <author>
        <name>Edali, Mert</name>
      </author>
      <author>
        <name>Ardestani, Babak Mahdavi</name>
      </author>
      <author>
        <name>Brewer, Russell</name>
      </author>
      <author>
        <name>Schrode, Katrina M</name>
      </author>
      <author>
        <name>Fujimoto, Kayo</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Schneider, John A</name>
      </author>
      <author>
        <name>Khanna, Aditya S</name>
      </author>
    </item>
    <item>
      <title>Drug Use, Family Support, and Depressive Symptoms Among Latinx Sexual Minority Men: A Longitudinal Analysis</title>
      <link>https://escholarship.org/uc/item/3pw4p1wt</link>
      <description>Family rejection has negative health consequences for Latinx sexual minority men&amp;nbsp;(LSMM). However, LSMM often reconcile with their families, a phenomenon cross-sectional studies miss. We analyzed longitudinal data from the Healthy Young Men’s Study in Los Angeles. We used individual fixed-effects Poisson regression to model changes over time in the associations among family support, drug use, and depressive symptoms. We found that (1) the initiation of drug use was associated with a 7.2% (Ratio=1.072, 95% CI 1.006 - 1.142, p = 0.03) increase in family support among LSMM who reported high depressive symptoms (depression subscale T-score ≥ 63) in at least one data wave; (2) a 1-unit increase in family support was associated with a 4.7% (RR = ;0.953, 95% CI 0.931 - 0.976, p &amp;lt; 0.001) decrease in the probability of high depressive symptoms; and (3) no significant association between a change in drug use and a change in high depressive symptoms. Over time, LSMM appear to benefit...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3pw4p1wt</guid>
      <pubDate>Tue, 7 Nov 2023 00:00:00 +0000</pubDate>
      <author>
        <name>del Pino, Homero E</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Shoptaw, Steven J</name>
        <uri>https://orcid.org/0000-0002-3583-0026</uri>
      </author>
      <author>
        <name>Schrode, Katrina</name>
      </author>
      <author>
        <name>Karlamangla, Arun</name>
      </author>
    </item>
    <item>
      <title>Grindr Users Take More Risks, but Are More Open to Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis: Could This Dating App Provide a Platform for HIV Prevention Outreach?</title>
      <link>https://escholarship.org/uc/item/8td6s5g7</link>
      <description>BACKGROUND: Technology has changed the way that men who have sex with men (MSM) seek sex. More than 60% of MSM in the United States use the internet and/or smartphone-based geospatial networking apps to find sex partners. We correlated use of the most popular app (Grindr) with sexual risk and prevention behavior among MSM.
METHODS: A nested cohort study was conducted between September 2018 and June 2019 among MSM receiving community-based human immunodeficiency virus (HIV) and sexually transmitted infection (STI) screening in central San Diego. During the testing encounter, participants were surveyed for demographics, substance use, risk behavior (previous 3 months), HIV pre-exposure prophylaxis (PrEP) use, and Grindr usage. Participants who tested negative for HIV and who were not on PrEP were offered immediate PrEP.
RESULTS: The study included 1256 MSM, 1090 of whom (86.8%) were not taking PrEP. Overall, 580 of 1256 (46%) participants indicated that they used Grindr in the previous...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8td6s5g7</guid>
      <pubDate>Sun, 22 Oct 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Hoenigl, Martin</name>
        <uri>https://orcid.org/0000-0002-1653-2824</uri>
      </author>
      <author>
        <name>Little, Susan J</name>
        <uri>https://orcid.org/0000-0002-7645-9737</uri>
      </author>
      <author>
        <name>Grelotti, David</name>
      </author>
      <author>
        <name>Skaathun, Britt</name>
      </author>
      <author>
        <name>Wagner, Gabriel A</name>
      </author>
      <author>
        <name>Weibel, Nadir</name>
        <uri>https://orcid.org/0000-0002-3457-4227</uri>
      </author>
      <author>
        <name>Stockman, Jamila K</name>
      </author>
      <author>
        <name>Smith, Davey M</name>
        <uri>https://orcid.org/0000-0003-3603-1733</uri>
      </author>
    </item>
    <item>
      <title>Sheroes: Feasibility and Acceptability of a Community-Driven, Group-Level HIV Intervention Program for Transgender Women</title>
      <link>https://escholarship.org/uc/item/66s3k6f4</link>
      <description>Transgender women experience disproportionate risk of HIV acquisition and transmission. We piloted ‘Sheroes’, a peer-led group-level intervention for transgender women of any HIV status emphasizing empowerment and gender affirmation to reduce HIV risk behaviors and increase social support. Participants (N = 77) were randomized to Sheroes (n = 39) or a time- and attention-matched control (n = 38). Sheroes is 5 weekly group sessions; topics include sexuality, communication, gender transition, and coping skills. Control participants attended 5 weekly group movie sessions. At 6-month follow up, HIV-negative and unknown status Sheroes participants reported reductions in condomless intercourse and improved social support compared to control. Among participants living with HIV, both the control and intervention groups reduced their total number of sex partners; this change was sustained at 6-month follow-up for Sheroes participants but not for control participants relative to baseline....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/66s3k6f4</guid>
      <pubDate>Sun, 15 Oct 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Sevelius, Jae M</name>
      </author>
      <author>
        <name>Neilands, Torsten B</name>
      </author>
      <author>
        <name>Dilworth, Samantha</name>
      </author>
      <author>
        <name>Castro, Danielle</name>
      </author>
      <author>
        <name>Johnson, Mallory O</name>
      </author>
    </item>
    <item>
      <title>What does it mean to be youth-friendly? Results from qualitative interviews with health care providers and clinic staff serving youth and young adults living with HIV</title>
      <link>https://escholarship.org/uc/item/4m31k94j</link>
      <description>PURPOSE: Given the consistent associations between younger age and numerous suboptimal clinical outcomes, there is a critical need for more research in youth living with human immunodeficiency virus (YLWH) and tailoring of health care delivery to the unique and complex needs of this population. The objective of this study was to examine the facilitators of and barriers to engagement in care among YLHW at the system and provider/staff level, as well as the barriers to using technology-based forms of communication with YLWH to improve retention and engagement in care.
PATIENTS AND METHODS: We conducted in-depth qualitative interviews with health care providers and staff members at the clinics and organizations serving YLWH in the San Francisco Bay Area.
RESULTS: We interviewed 17 health care providers and staff members with a mean of 8 years of experience in providing clinical care to YLWH. Interviewees noted various facilitators of and barriers to engagement in care among YLWH,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4m31k94j</guid>
      <pubDate>Sun, 15 Oct 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Saberi, Parya</name>
        <uri>https://orcid.org/0000-0002-3793-5112</uri>
      </author>
      <author>
        <name>Ming, Kristin</name>
        <uri>https://orcid.org/0000-0002-0688-9002</uri>
      </author>
      <author>
        <name>Dawson-Rose, Carol</name>
        <uri>https://orcid.org/0000-0001-6066-1853</uri>
      </author>
    </item>
    <item>
      <title>Life Chaos is Associated with Reduced HIV Testing, Engagement in Care, and ART Adherence Among Cisgender Men and Transgender Women upon Entry into Jail</title>
      <link>https://escholarship.org/uc/item/7wn7r7bz</link>
      <description>Life chaos, the perceived inability to plan for and anticipate the future, may be a barrier to the HIV care continuum for people living with HIV who experience incarceration. Between December 2012 and June 2015, we interviewed 356 adult cisgender men and transgender women living with HIV in Los Angeles County Jail. We assessed life chaos using the Confusion, Hubbub, and Order Scale (CHAOS)&amp;nbsp;and conducted regression analyses to estimate the association between life chaos and care continuum. Forty-eight percent were diagnosed with HIV while incarcerated, 14% were engaged in care 12&amp;nbsp;months prior to incarceration, mean antiretroviral adherence was 65%, and 68% were virologically suppressed. Adjusting for sociodemographics, HIV-related stigma, and social support, higher life chaos was associated with greater likelihood of diagnosis while incarcerated, lower likelihood of engagement in care, and lower adherence. There was no statistically significant association between life...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7wn7r7bz</guid>
      <pubDate>Thu, 21 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Takada, Sae</name>
      </author>
      <author>
        <name>Ettner, Susan L</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Garland, Wendy H</name>
      </author>
      <author>
        <name>Shoptaw, Steve J</name>
        <uri>https://orcid.org/0000-0002-3583-0026</uri>
      </author>
      <author>
        <name>Cunningham, William E</name>
      </author>
    </item>
    <item>
      <title>Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial</title>
      <link>https://escholarship.org/uc/item/5mv5p2gj</link>
      <description>BACKGROUND: People living with HIV (PLWH) often experience decreases in HIV viral suppression (VS) after release from jail. The Linking Inmates to Care in LA (LINK LA) peer navigation intervention helped maintain VS 12 months after release from jail compared to standard of care. In this study, we analyzed correlates of substance use and tested whether substance use was an independent correlate of decreased VS in LINK LA participants.
METHODS: We analyzed LINK LA data collected at baseline, 3, and 12 months. We defined high-risk drug use as any reported methamphetamine, cocaine, or opioid use in the 30 days prior to a study visit (or jail entry at baseline). We used generalized linear mixed models to test associations of sociodemographic variables with type of substance used, and we tested correlates of VS while controlling for time, the intervention, and their interaction.
RESULTS: At baseline (n = 356), 71% of participants reported high-risk drug use: 58%, methamphetamine; 17%,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5mv5p2gj</guid>
      <pubDate>Thu, 21 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Goodman-Meza, David</name>
      </author>
      <author>
        <name>Shoptaw, Steve</name>
        <uri>https://orcid.org/0000-0002-3583-0026</uri>
      </author>
      <author>
        <name>Weiss, Robert E</name>
        <uri>https://orcid.org/0000-0003-3648-8522</uri>
      </author>
      <author>
        <name>Nakazono, Terry</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Takada, Sae</name>
      </author>
      <author>
        <name>Garland, Wendy H</name>
      </author>
      <author>
        <name>Cunningham, William E</name>
      </author>
    </item>
    <item>
      <title>Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area</title>
      <link>https://escholarship.org/uc/item/9mg3d4c4</link>
      <description>PURPOSE: Little is known about food insecurity and unmet subsistence needs and their association with antiretroviral therapy adherence among youth and young adults living with HIV (YLWH).
METHODS: We conducted a cross-sectional survey to examine this association in 101 YLWH (aged 18-29&amp;nbsp;years). Poisson regression models with robust standard errors were used to estimate adjusted risk ratios (RRs) and 95% confidence intervals (CIs).
RESULTS: Approximately 51.7% of participants experienced at least one unmet subsistence need (difficulty finding enough to eat [36.6%], clothing [22.8%], place to sleep [21.8%], place to wash [17.8%], and bathroom [15.8%]), and 64.2% reported being food insecure. For every additional unmet need, the risk of very good/excellent adherence was reduced by 15% (RR&amp;nbsp;= .85; 95% CI&amp;nbsp;=&amp;nbsp;.72-.99; p value&amp;nbsp;= .04). The risk of very good/excellent adherence was lowered by 39% (RR&amp;nbsp;= .61; 95% CI&amp;nbsp;= .43-.87; p value&amp;nbsp;= .005) among food...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9mg3d4c4</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Reeder, Christian</name>
      </author>
      <author>
        <name>Neilands, Torsten B</name>
      </author>
      <author>
        <name>Palar, Kartika</name>
      </author>
      <author>
        <name>Saberi, Parya</name>
        <uri>https://orcid.org/0000-0002-3793-5112</uri>
      </author>
    </item>
    <item>
      <title>Effective use of pre-exposure prophylaxis (PrEP) Among stimulant users with multiple condomless sex partners: a longitudinal study of men who have sex with men in Los Angeles</title>
      <link>https://escholarship.org/uc/item/8w08s378</link>
      <description>PrEP's potential benefit for men who have sex with men (MSM) who use stimulants may be limited by adherence or prescriber willingness to recommend PrEP due to concerns of non-compliance. Using data from PATH-PrEP, a 48-week study evaluating PrEP for MSM in Los Angeles, we modeled an interaction between stimulant use and condomless sex with multiple partners (CAS-MP) on prevention-effective dried blood spot tenofovir-diphosphate concentrations. At week 4, participants reporting stimulant use and CAS-MP had a decreased odds of prevention-effective adherence compared to non-stimulant use and non-CAS-MP (AOR 0.15, 95% CI 0.04-0.57). From week 4-48, participants reporting stimulant use and CAS-MP had increased odds of prevention-effective adherence (AOR 1.06 per week, 95%CI 1.01-1.12). Participants reporting CAS-MP without stimulant use had no significant change in prevention-effective adherence (AOR 0.99 per week, 95%CI 0.96-1.02). Stimulant use moderated the association of CAS-MP...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8w08s378</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Goodman-Meza, David</name>
      </author>
      <author>
        <name>Beymer, Matthew R</name>
      </author>
      <author>
        <name>Kofron, Ryan M</name>
      </author>
      <author>
        <name>Amico, K Rivet</name>
      </author>
      <author>
        <name>Psaros, Christina</name>
      </author>
      <author>
        <name>Bushman, Lane R</name>
      </author>
      <author>
        <name>Anderson, Peter L</name>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Jordan, Wilbert C</name>
      </author>
      <author>
        <name>Rooney, James F</name>
      </author>
      <author>
        <name>Wohl, Amy R</name>
      </author>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
    </item>
    <item>
      <title>HIV transmission networks among transgender women in Los Angeles County, CA, USA: a phylogenetic analysis of surveillance data</title>
      <link>https://escholarship.org/uc/item/58t2r8pc</link>
      <description>BACKGROUND: Transgender women are among the groups at highest risk for HIV infection, with a prevalence of 27·7% in the USA; and despite this known high risk, undiagnosed infection is common in this population. We set out to identify transgender women and their partners in a molecular transmission network to prioritise public health activities.
METHODS: Since 2006, HIV protease and reverse transcriptase gene (pol) sequences from drug resistance testing have been reported to the Los Angeles County Department of Public Health and linked to demographic data, gender, and HIV transmission risk factor data for each case in the enhanced HIV/AIDS Reporting System. We reconstructed a molecular transmission network by use of HIV-TRAnsmission Cluster Engine (with a pairwise genetic distance threshold of 0·015 substitutions per site) from the earliest pol sequences from 22 398 unique individuals, including 412 (2%) self-identified transgender women. We examined the possible predictors of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/58t2r8pc</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Ragonnet-Cronin, Manon</name>
      </author>
      <author>
        <name>Hu, Yunyin W</name>
      </author>
      <author>
        <name>Morris, Sheldon R</name>
      </author>
      <author>
        <name>Sheng, Zhijuan</name>
      </author>
      <author>
        <name>Poortinga, Kathleen</name>
      </author>
      <author>
        <name>Wertheim, Joel O</name>
      </author>
    </item>
    <item>
      <title>Perceived Versus Calculated HIV Risk</title>
      <link>https://escholarship.org/uc/item/2x6068bv</link>
      <description>BACKGROUND: Inaccurate HIV risk perception by men who have sex with men is a barrier to HIV prevention. Providing information about objective HIV risk could improve pre-exposure prophylaxis (PrEP) uptake.
METHODS: PrEP Accessibility Research &amp;amp; Evaluation 2 (PrEPARE2) was a randomized controlled trial of men who have sex with men to determine whether an objective risk score affects future PrEP uptake. Participants completed a baseline survey to assess demographics, risk behaviors, and HIV self-perceived risk (SPR). The survey generated a calculated HIV risk (CalcR) score, estimating HIV risk based on reported condomless anal intercourse and sexually transmitted infections, and was provided to individuals in the intervention arm. Participants were contacted 8 weeks later to determine whether they initiated PrEP.
RESULTS: Of 171 participants (median age 32 years; 37% Hispanic or non-Hispanic Black; median 5 sexual partners in the past 6 months), 81% had heard of PrEP, and 57%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2x6068bv</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Jain, Sonia</name>
      </author>
      <author>
        <name>Mulvihill, Evan</name>
      </author>
      <author>
        <name>Sun, Shelly</name>
      </author>
      <author>
        <name>Hanashiro, Marvin</name>
      </author>
      <author>
        <name>Ellorin, Eric</name>
      </author>
      <author>
        <name>Graber, Sara</name>
      </author>
      <author>
        <name>Haubrich, Richard</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
    </item>
    <item>
      <title>Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy</title>
      <link>https://escholarship.org/uc/item/28z2n4b9</link>
      <description>Most people living with HIV (PLWH) are coinfected with cytomegalovirus (CMV). Subclinical CMV replication is associated with immune dysfunction and with increased HIV DNA in antiretroviral therapy (ART)-naive and -suppressed PLWH. To identify immunological mechanisms by which CMV could favor HIV persistence, we analyzed 181 peripheral blood mononuclear cell (PBMC) samples from 64 PLWH starting ART during early HIV infection with subsequent virologic suppression up to 58 months. In each sample, we measured levels of CMV and Epstein-Barr virus (EBV) DNA by droplet digital PCR (ddPCR). We also measured expression of immunological markers for activation (HLA-DR&lt;sup&gt;+&lt;/sup&gt; CD38&lt;sup&gt;+&lt;/sup&gt;), cycling (Ki-67&lt;sup&gt;+&lt;/sup&gt;), degranulation (CD107a&lt;sup&gt;+&lt;/sup&gt;), and the immune checkpoint protein PD-1 on CD4&lt;sup&gt;+&lt;/sup&gt; and CD8&lt;sup&gt;+&lt;/sup&gt; T cell memory subsets. Significant differences in percentages of lymphocyte markers by CMV/EBV shedding were identified using generalized linear mixed-effects...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28z2n4b9</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Christensen-Quick, Aaron</name>
      </author>
      <author>
        <name>Massanella, Marta</name>
      </author>
      <author>
        <name>Frick, Andrew</name>
      </author>
      <author>
        <name>Rawlings, Stephen A</name>
      </author>
      <author>
        <name>Spina, Celsa</name>
      </author>
      <author>
        <name>Vargas-Meneses, Milenka</name>
      </author>
      <author>
        <name>Schrier, Rachel</name>
      </author>
      <author>
        <name>Nakazawa, Masato</name>
      </author>
      <author>
        <name>Anderson, Christy</name>
      </author>
      <author>
        <name>Gianella, Sara</name>
      </author>
    </item>
    <item>
      <title>Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective</title>
      <link>https://escholarship.org/uc/item/2006t799</link>
      <description>Disparities in HIV treatment outcomes among youth living with HIV (YLWH) present a challenge for ending the HIV epidemic. Antiretroviral therapy (ART) adherence can be impacted by comorbidities such as mental health and substance use. Technology use has shown promise in increasing access to mental health and substance use services. Using a mixed-methods approach, we conducted formative research to describe the relationship between mental health, substance use, and medication adherence in 18-29 year-old YLWH, and explored technology use as an approach to supporting these services. Among 101 YLWH, ART adherence was significantly negatively associated with mental health measures such as depression, trauma, and adverse childhood experiences and marijuana and stimulants use. Depression had the highest level of relative importance in its association with ART adherence. During in-depth interviews with 29 participants, barriers to and facilitators of accessing and maintaining mental health...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2006t799</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Saberi, Parya</name>
        <uri>https://orcid.org/0000-0002-3793-5112</uri>
      </author>
      <author>
        <name>Rose, Carol Dawson</name>
      </author>
      <author>
        <name>Wootton, Angie R</name>
      </author>
      <author>
        <name>Ming, Kristin</name>
        <uri>https://orcid.org/0000-0002-0688-9002</uri>
      </author>
      <author>
        <name>Legnitto, Dominique</name>
      </author>
      <author>
        <name>Jeske, Melanie</name>
      </author>
      <author>
        <name>Pollack, Lance M</name>
      </author>
      <author>
        <name>Johnson, Mallory O</name>
      </author>
      <author>
        <name>Gruber, Valerie A</name>
      </author>
      <author>
        <name>Neilands, Torsten B</name>
      </author>
    </item>
    <item>
      <title>Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals</title>
      <link>https://escholarship.org/uc/item/02k2z3rb</link>
      <description>Purpose of ReviewPre-exposure prophylaxis (PrEP) is a potent HIV prevention strategy, but uptake of daily oral PrEP remains low. This review covers PrEP agents currently available and agents and modalities under investigation.Recent FindingsInjectable ARV preparations have high acceptability among users but are likely to require adherence to 8-week interval injections. Topical microbicide gels and vaginal rings have underperformed by intention-to-treat analyses in efficacy studies, at least in large part due to challenges with adherence and/or sustained use. However, daily oral TDF-FTC also underperformed in randomized, placebo-controlled trials compared to expectations and subsequent real-world pragmatic use.SummaryOn-demand (2-1-1 dosing strategy for MSM) and injectable PrEP appear to be acceptable among participants in clinical trials. These modalities are particularly compelling alternatives for individuals who either do not want to take a daily medication (both on-demand...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/02k2z3rb</guid>
      <pubDate>Wed, 20 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Beymer, Matthew R</name>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Pulsipher, Craig</name>
      </author>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
    </item>
    <item>
      <title>Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California</title>
      <link>https://escholarship.org/uc/item/9x8371jv</link>
      <description>BACKGROUND: Pre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at-risk populations. However, concerns exist over the potential for an increase in STIs following PrEP initiation. The objective of this study is to compare the STI incidence before and after PrEP initiation within subjects among a cohort of men who have sex with men in Los Angeles, California.
METHODS: The present study used data from patients who initiated PrEP services at the Los Angeles LGBT Center between October 2015 and October 2016 (n=275). A generalised linear mixed model was used with a case-crossover design to determine if there was a significant difference in STIs within subjects 365 days before (before-PrEP period) and 365 days after PrEP initiation (after-PrEP period).
RESULTS: In a generalised linear mixed model, there were no significant differences in urethral gonorrhoea (P=0.95), rectal gonorrhoea (P=0.33), pharyngeal gonorrhoea (P=0.65) or urethral chlamydia (P=0.71)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9x8371jv</guid>
      <pubDate>Tue, 19 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Beymer, Matthew R</name>
      </author>
      <author>
        <name>DeVost, Michelle A</name>
      </author>
      <author>
        <name>Weiss, Robert E</name>
        <uri>https://orcid.org/0000-0003-3648-8522</uri>
      </author>
      <author>
        <name>Dierst-Davies, Rhodri</name>
      </author>
      <author>
        <name>Shover, Chelsea L</name>
      </author>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
      <author>
        <name>Beniasians, Corinne</name>
      </author>
      <author>
        <name>Talan, Ali J</name>
      </author>
      <author>
        <name>Flynn, Risa P</name>
      </author>
      <author>
        <name>Krysiak, Robyn</name>
      </author>
      <author>
        <name>McLaughlin, Kayla</name>
      </author>
      <author>
        <name>Bolan, Robert K</name>
      </author>
    </item>
    <item>
      <title>Effect of cytomegalovirus and Epstein–Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals</title>
      <link>https://escholarship.org/uc/item/9d11v4g0</link>
      <description>BACKGROUND: HIV-infection is associated with dramatic changes in the intestinal mucosa. The impact of other viral pathogens is unclear.
METHODS: One hundred and eight (108) biopsies from left and right colon (n = 79) and terminal ileum (n = 29) were collected from 19 HIV-infected and 22 HIV-uninfected participants. Levels of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) DNA were measured by droplet digital PCR. Mucosal gene expression was measured via multiplex-assay. Microbiome analysis was performed using bacterial 16S-rDNA-pyrosequencing. The effect of CMV and EBV replication on the microbiome composition and mRNA-expression of selected cytokines (IL-6, IFN-γ, IL-1β, CCL2, IL-8, and IFN-β1) was evaluated.
RESULTS: Overall, CMV and EBV were detected in at least one intestinal site in 60.5 and 78.9% of participants, respectively. HIV-infected individuals demonstrated less detectable CMV (PB = 0.02); CMV was more frequently detected in terminal ileum than colon (PB = 0.05)....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9d11v4g0</guid>
      <pubDate>Tue, 19 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Gianella, Sara</name>
      </author>
      <author>
        <name>Chaillon, Antoine</name>
        <uri>https://orcid.org/0000-0001-9490-3857</uri>
      </author>
      <author>
        <name>Mutlu, Ece A</name>
      </author>
      <author>
        <name>Engen, Phillip A</name>
      </author>
      <author>
        <name>Voigt, Robin M</name>
      </author>
      <author>
        <name>Keshavarzian, Ali</name>
      </author>
      <author>
        <name>Losurdo, John</name>
      </author>
      <author>
        <name>Chakradeo, Prachi</name>
      </author>
      <author>
        <name>Lada, Steven M</name>
      </author>
      <author>
        <name>Nakazawa, Masato</name>
      </author>
      <author>
        <name>Landay, Alan L</name>
      </author>
    </item>
    <item>
      <title>SHMT2 and the BRCC36/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy</title>
      <link>https://escholarship.org/uc/item/4s43r9k1</link>
      <description>HIV-1 Tat is a key regulator of viral transcription, however little is known about the mechanisms that control its turnover in T cells. Here we use a novel proteomics technique, called DiffPOP, to identify the molecular target of JIB-04, a small molecule compound that potently and selectively blocks HIV-1 Tat expression, transactivation, and virus replication in T cell lines. Mass-spectrometry analysis of whole-cell extracts from 2D10 Jurkat T cells revealed that JIB-04 targets Serine Hydroxymethyltransferase 2 (SHMT2), a regulator of glycine biosynthesis and an adaptor for the BRCC36 K63Ub-specific deubiquitinase in the BRISC complex. Importantly, knockdown of SHMT1,2 or BRCC36, or exposure of cells to JIB-04, strongly increased Tat K63Ub-dependent destruction via autophagy. Moreover, point mutation of multiple lysines in Tat, or knockdown of BRCC36 or SHMT1,2, was sufficient to prevent destruction of Tat by JIB-04. We conclude that HIV-1 Tat levels are regulated through K63Ub-selective...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4s43r9k1</guid>
      <pubDate>Tue, 19 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Xu, Muyu</name>
      </author>
      <author>
        <name>Moresco, James J</name>
      </author>
      <author>
        <name>Chang, Max</name>
      </author>
      <author>
        <name>Mukim, Amey</name>
      </author>
      <author>
        <name>Smith, Davey</name>
        <uri>https://orcid.org/0000-0003-3603-1733</uri>
      </author>
      <author>
        <name>Diedrich, Jolene K</name>
      </author>
      <author>
        <name>Yates, John R</name>
      </author>
      <author>
        <name>Jones, Katherine A</name>
      </author>
    </item>
    <item>
      <title>Are Unequal Policies in Pre-Exposure Prophylaxis Uptake Needed to Improve Equality? An Examination Among Men Who Have Sex with Men in Los Angeles County</title>
      <link>https://escholarship.org/uc/item/3jk0n3v1</link>
      <description>Racial and ethnic minority men who have sex with men (MSM) are disproportionately affected by HIV/AIDS in Los Angeles County (LAC), an important epicenter in the battle to end HIV. We examine tradeoffs between effectiveness and equality of pre-exposure prophylaxis (PrEP) allocation strategies among different racial and ethnic groups of MSM in LAC and provide a framework for quantitatively evaluating disparities in HIV outcomes. To do this, we developed a microsimulation model of HIV among MSM in LAC using county epidemic surveillance and survey data to capture demographic trends and subgroup-specific partnership patterns, disease progression, patterns of PrEP use, and patterns for viral suppression. We limit analysis to MSM, who bear most of the burden of HIV/AIDS in LAC. We simulated interventions where 3000, 6000, or 9000 PrEP prescriptions are provided annually in addition to current levels, following different allocation scenarios to each racial/ethnic group (Black, Hispanic,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3jk0n3v1</guid>
      <pubDate>Sat, 9 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Nguyen, Anthony</name>
      </author>
      <author>
        <name>Drabo, Emmanuel Fulgence</name>
      </author>
      <author>
        <name>Garland, Wendy H</name>
      </author>
      <author>
        <name>Moucheraud, Corrina</name>
        <uri>https://orcid.org/0000-0001-7862-7928</uri>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Leibowitz, Arleen</name>
        <uri>https://orcid.org/0000-0001-6970-0564</uri>
      </author>
      <author>
        <name>Suen, Sze-chuan</name>
      </author>
    </item>
    <item>
      <title>Integrating Virus Monitoring Strategies for Safe Non-Potable Water Reuse</title>
      <link>https://escholarship.org/uc/item/5g59f6sr</link>
      <description>Wastewater reclamation and reuse have the potential to supplement water supplies, offering resiliency in times of drought and helping meet increased water demands associated with population growth. Non-potable water reuse represents the largest potential reuse market. Yet economic constraints for new water reuse infrastructure and safety concerns due to microbial water quality, and especially viral pathogen exposure, limit widespread implementation of water reuse. Cost-effective, real-time methods to measure or indicate viral quality of recycled water would do much to instill greater confidence in the practice. This manuscript discusses advancements in monitoring and modeling of viral health risks in the context of water reuse. First, we describe the current wastewater reclamation processes and treatment technologies with an emphasis on virus removal. Second, we review technologies for the measurement of viruses, both culture- and molecular-based, along with their advantages and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5g59f6sr</guid>
      <pubDate>Tue, 5 Sep 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Jiang, Sunny C</name>
        <uri>https://orcid.org/0000-0002-4993-8038</uri>
      </author>
      <author>
        <name>Bischel, Heather N</name>
        <uri>https://orcid.org/0000-0001-8335-0601</uri>
      </author>
      <author>
        <name>Goel, Ramesh</name>
      </author>
      <author>
        <name>Rosso, Diego</name>
        <uri>https://orcid.org/0000-0002-6879-3110</uri>
      </author>
      <author>
        <name>Sherchan, Samendra P</name>
      </author>
      <author>
        <name>Whiteson, Katrine L</name>
        <uri>https://orcid.org/0000-0002-5423-6014</uri>
      </author>
      <author>
        <name>Yan, Tao</name>
      </author>
      <author>
        <name>Solo-Gabriele, Helena M</name>
      </author>
    </item>
    <item>
      <title>Managing HIV During the COVID-19 Pandemic: A Study of Help-Seeking Behaviors on a Social Media Forum</title>
      <link>https://escholarship.org/uc/item/2n55w7gz</link>
      <description>Although numerous editorials claim the COVID-19 pandemic has disproportionately impacted vulnerable populations, particularly those affected by HIV, these claims have received limited empirical evaluation. We analyzed posts to Reddit’s r/HIVAIDS from January 3, 2012 through April 30, 2022 to (a) assess changes in the volume of posts during the pandemic and (b) determine the needs of HIV affected communities. There were cumulatively 100% (95%CI: 75–126) more posts than expected since the US declared a pandemic emergency. The most prevalent themes in these posts were for obtaining an HIV + diagnosis (representing 34% (95%CI:29–40) of all posts), seeking HIV treatment (20%; 95%CI:16–25), finding psychosocial support (16%; 95%CI:12–20), and tracking disease progression (8%; 95%CI:5–11). Discussions about PrEP and PEP were the least common, representing less than 6% of all posts each. Social media has increasingly become an important health resource for vulnerable populations seeking...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2n55w7gz</guid>
      <pubDate>Wed, 30 Aug 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Ayers, John W</name>
      </author>
      <author>
        <name>Zhu, Zechariah</name>
      </author>
      <author>
        <name>Harrigian, Keith</name>
      </author>
      <author>
        <name>Wightman, Gwenyth P</name>
      </author>
      <author>
        <name>Dredze, Mark</name>
      </author>
      <author>
        <name>Strathdee, Steffanie A</name>
      </author>
      <author>
        <name>Smith, Davey M</name>
        <uri>https://orcid.org/0000-0003-3603-1733</uri>
      </author>
    </item>
    <item>
      <title>Impact of COVID-19 Response on the HIV Epidemic in Men Who Have Sex With Men in San Francisco County: The Importance of Rapid Return to Normalcy</title>
      <link>https://escholarship.org/uc/item/8467m8bb</link>
      <description>BACKGROUND: In response to the COVID-19 pandemic, San Francisco County (SFC) had to shift many nonemergency health care resources to COVID-19, reducing HIV control resources. We sought to quantify COVID-19 effects on HIV burden among men who have sex with men (MSM) as SFC returns to pre-COVID service levels and progresses toward the Ending the HIV Epidemic (EHE) goals.
SETTING: Microsimulation model of MSM in SFC tracking HIV progression and treatment.
METHODS: Scenario analysis where services affected by COVID-19 [testing, care engagement, pre-exposure prophylaxis (PrEP) uptake, and retention] return to pre-COVID levels by the end of 2022 or 2025, compared against a counterfactual where COVID-19 changes never occurred. We also examined scenarios where resources are prioritized to reach new patients or retain of existing patients from 2023 to 2025 before all services return to pre-COVID levels.
RESULTS: The annual number of MSM prescribed PrEP, newly acquired HIV, newly diagnosed,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8467m8bb</guid>
      <pubDate>Tue, 11 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Liang, Citina</name>
      </author>
      <author>
        <name>Suen, Sze-chuan</name>
      </author>
      <author>
        <name>Nguyen, Anthony</name>
      </author>
      <author>
        <name>Moucheraud, Corrina</name>
        <uri>https://orcid.org/0000-0001-7862-7928</uri>
      </author>
      <author>
        <name>Hsu, Ling</name>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Charlebois, Edwin D</name>
        <uri>https://orcid.org/0000-0001-7237-2119</uri>
      </author>
      <author>
        <name>Steward, Wayne T</name>
      </author>
    </item>
    <item>
      <title>The role of oxidative stress in the pathogenesis of infections with coronaviruses</title>
      <link>https://escholarship.org/uc/item/4p79p1nm</link>
      <description>Coronaviruses can cause serious respiratory tract infections and may also impact other end organs such as the central nervous system, the lung and the heart. The coronavirus disease 2019 (COVID-19) has had a devastating impact on humanity. Understanding the mechanisms that contribute to the pathogenesis of coronavirus infections, will set the foundation for development of new treatments to attenuate the impact of infections with coronaviruses on host cells and tissues. During infection of host cells, coronaviruses trigger an imbalance between increased production of reactive oxygen species (ROS) and reduced antioxidant host responses that leads to increased redox stress. Subsequently, increased redox stress contributes to reduced antiviral host responses and increased virus-induced inflammation and apoptosis that ultimately drive cell and tissue damage and end organ disease. However, there is limited understanding how different coronaviruses including SARS-CoV-2, manipulate cellular...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4p79p1nm</guid>
      <pubDate>Tue, 11 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Gain, Chandrima</name>
      </author>
      <author>
        <name>Song, Sihyeong</name>
      </author>
      <author>
        <name>Angtuaco, Tyler</name>
      </author>
      <author>
        <name>Satta, Sandro</name>
      </author>
      <author>
        <name>Kelesidis, Theodoros</name>
        <uri>https://orcid.org/0000-0002-8463-3811</uri>
      </author>
    </item>
    <item>
      <title>Using Microsimulation Modeling to Inform EHE Implementation Strategies in Los Angeles County</title>
      <link>https://escholarship.org/uc/item/94k6f00g</link>
      <description>BACKGROUND: Pre-exposure prophylaxis (PrEP) is essential to ending HIV. Yet, uptake remains uneven across racial and ethnic groups. We aimed to estimate the impacts of alternative PrEP implementation strategies in Los Angeles County.
SETTING: Men who have sex with men, residing in Los Angeles County.
METHODS: We developed a microsimulation model of HIV transmission, with inputs from key local stakeholders. With this model, we estimated the 15-year (2021-2035) health and racial and ethnic equity impacts of 3 PrEP implementation strategies involving coverage with 9000 additional PrEP units annually, above the Status-quo coverage level. Strategies included PrEP allocation equally (strategy 1), proportionally to HIV prevalence (strategy 2), and proportionally to HIV diagnosis rates (strategy 3), across racial and ethnic groups. We measured the degree of relative equalities in the distribution of the health impacts using the Gini index (G) which ranges from 0 (perfect equality, with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/94k6f00g</guid>
      <pubDate>Fri, 7 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Drabo, Emmanuel F</name>
      </author>
      <author>
        <name>Moucheraud, Corrina</name>
        <uri>https://orcid.org/0000-0001-7862-7928</uri>
      </author>
      <author>
        <name>Nguyen, Anthony</name>
      </author>
      <author>
        <name>Garland, Wendy H</name>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Leibowitz, Arleen</name>
        <uri>https://orcid.org/0000-0001-6970-0564</uri>
      </author>
      <author>
        <name>Suen, Sze-chuan</name>
      </author>
    </item>
    <item>
      <title>Community engagement to improve access to healthcare: a comparative case study to advance implementation science for transgender health equity</title>
      <link>https://escholarship.org/uc/item/1d87k679</link>
      <description>BackgroundRecent calls to action have been made for Implementation Science to attend to health inequities at the intersections of race, gender, and social injustice in the United States. Transgender people, particularly Black and Latina transgender women, experience a range of health inequities and social injustices. In this study, we compared two processes of transgender community engagement in Los Angeles and in Chicago as an implementation strategy to address inequitable access to care; we adapted and extended the Exploration Planning Implementation and Sustainment (EPIS) framework for transgender health equity.MethodsA comparative case method and the EPIS framework were used to examine parallel implementation strategies of transgender community engagement to expand access to care. To foster conceptual development and adaptation of EPIS for trans health equity, the comparative case method required detailed description, exploration, and analyses of the community-engagement processes...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1d87k679</guid>
      <pubDate>Mon, 3 Jul 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Thompson, Hale M</name>
      </author>
      <author>
        <name>Clement, Allison M</name>
      </author>
      <author>
        <name>Ortiz, Reyna</name>
      </author>
      <author>
        <name>Preston, Toni Marie</name>
      </author>
      <author>
        <name>Quantrell, Ava L Wells</name>
      </author>
      <author>
        <name>Enfield, Michelle</name>
      </author>
      <author>
        <name>King, AJ</name>
      </author>
      <author>
        <name>Klosinski, Lee</name>
      </author>
      <author>
        <name>Reback, Cathy J</name>
      </author>
      <author>
        <name>Hamilton, Alison</name>
      </author>
      <author>
        <name>Milburn, Norweeta</name>
      </author>
    </item>
    <item>
      <title>The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells</title>
      <link>https://escholarship.org/uc/item/6119f2q2</link>
      <description>An oral antiviral against SARS-CoV-2 that also attenuates inflammatory instigators of severe COVID-19 is not available to date. Herein, we show that the apoA-I mimetic peptide 4&amp;nbsp;F inhibits Spike mediated viral entry and has antiviral activity against SARS-CoV-2 in human lung epithelial Calu3 and Vero-E6 cells. In SARS-CoV-2 infected Calu3 cells, 4&amp;nbsp;F upregulated inducers of the interferon pathway such as MX-1 and Heme oxygenase 1 (HO-1) and downregulated mitochondrial reactive oxygen species (mito-ROS) and CD147, a host protein that mediates viral entry. 4&amp;nbsp;F also reduced associated cellular apoptosis and secretion of IL-6 in both SARS-CoV-2 infected Vero-E6 and Calu3 cells. Thus, 4&amp;nbsp;F attenuates &lt;i&gt;in vitro&lt;/i&gt; SARS-CoV-2 replication, associated apoptosis in epithelial cells and secretion of IL-6, a major cytokine related to COVID-19 morbidity. Given established safety of 4&amp;nbsp;F in humans, clinical studies are warranted to establish 4&amp;nbsp;F as therapy for COVID-19.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6119f2q2</guid>
      <pubDate>Sat, 24 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Kelesidis, Theodoros</name>
        <uri>https://orcid.org/0000-0002-8463-3811</uri>
      </author>
      <author>
        <name>Sharma, Madhav</name>
      </author>
      <author>
        <name>Petcherski, Anton</name>
      </author>
      <author>
        <name>Hugo, Cristelle</name>
      </author>
      <author>
        <name>O’Connor, Ellen</name>
      </author>
      <author>
        <name>Hultgren, Nan W</name>
      </author>
      <author>
        <name>Ritou, Eleni</name>
      </author>
      <author>
        <name>Williams, David S</name>
      </author>
      <author>
        <name>Shirihai, Orian S</name>
      </author>
      <author>
        <name>Reddy, Srinivasa T</name>
      </author>
    </item>
    <item>
      <title>Informing California’s Plan to Enhance HIV Screening in the Ending the HIV Epidemic Initiative</title>
      <link>https://escholarship.org/uc/item/096581rq</link>
      <description>The CDC recommends that everyone have at least one HIV test in their lifetime. However, analyses of California Health Interview Survey data showed that in 2017 only half of Californians had ever received an HIV test. Non-Hispanic Black (64.8%) and Hispanic adults (54.7%) had higher lifetime testing rates than non-Hispanic White adults (48.8%). In multivariable analyses non-Hispanic African American adults had twice and Hispanic adults 1.2 times the odds of lifetime HIV testing as non-Hispanic White adults. The CDC recommends annual HIV testing for higher-risk individuals. Independent of race/ethnicity, heterosexual men with multiple sex partners had lower annual testing rates than other high-risk individuals. Annual testing was unrelated to education level and poverty, but was related to number of doctor visits. HIV screening rates among heterosexual men with multiple partners could be increased by targeting HIV screening to non-medical settings in California's eight Ending the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/096581rq</guid>
      <pubDate>Sat, 24 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Leibowitz, Arleen</name>
        <uri>https://orcid.org/0000-0001-6970-0564</uri>
      </author>
      <author>
        <name>Tan, Diane</name>
      </author>
    </item>
    <item>
      <title>ApoA-I mimetics attenuate macrophage activation in chronic treated HIV</title>
      <link>https://escholarship.org/uc/item/6cn9w57h</link>
      <description>OBJECTIVES: Despite antiretroviral therapy (ART), there is an unmet need for therapies to mitigate immune activation in HIV infection. The goal of this study is to determine whether the apoA-I mimetics 6F and 4F attenuate macrophage activation in chronic HIV.
DESIGN: Preclinical assessment of the in-vivo impact of Tg6F and the ex-vivo impact of apoA-I mimetics on biomarkers of immune activation and gut barrier dysfunction in treated HIV.
METHODS: We used two humanized murine models of HIV infection to determine the impact of oral Tg6F with ART (HIV+ART+Tg6F+) on innate immune activation (plasma human sCD14, sCD163) and gut barrier dysfunction [murine I-FABP, endotoxin (LPS), LPS-binding protein (LBP), murine sCD14]. We also used gut explants from 10 uninfected and 10 HIV-infected men on potent ART and no morbidity, to determine the impact of ex-vivo treatment with 4F for 72 h on secretion of sCD14, sCD163, and I-FABP from gut explants.
RESULTS: When compared with mice treated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6cn9w57h</guid>
      <pubDate>Thu, 15 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Mu, William</name>
      </author>
      <author>
        <name>Sharma, Madhav</name>
      </author>
      <author>
        <name>Heymans, Rachel</name>
      </author>
      <author>
        <name>Ritou, Eleni</name>
      </author>
      <author>
        <name>Rezek, Valerie</name>
      </author>
      <author>
        <name>Hamid, Philip</name>
      </author>
      <author>
        <name>Kossyvakis, Athanasios</name>
      </author>
      <author>
        <name>Sen Roy, Shubhendu</name>
      </author>
      <author>
        <name>Grijalva, Victor</name>
      </author>
      <author>
        <name>Chattopadhyay, Arnab</name>
      </author>
      <author>
        <name>Papesh, Jeremy</name>
      </author>
      <author>
        <name>Meriwether, David</name>
      </author>
      <author>
        <name>Kitchen, Scott G</name>
      </author>
      <author>
        <name>Fogelman, Alan M</name>
      </author>
      <author>
        <name>Reddy, Srinivasa T</name>
      </author>
      <author>
        <name>Kelesidis, Theodoros</name>
        <uri>https://orcid.org/0000-0002-8463-3811</uri>
      </author>
    </item>
    <item>
      <title>Sorting by Race/Ethnicity Across HIV Genetic Transmission Networks in Three Major Metropolitan Areas in the United States</title>
      <link>https://escholarship.org/uc/item/5jq8x528</link>
      <description>An important component underlying the disparity in HIV risk between race/ethnic groups is the preferential transmission between individuals in the same group. We sought to quantify transmission between different race/ethnicity groups and measure racial assortativity in HIV transmission networks in major metropolitan areas in the United States. We reconstructed HIV molecular transmission networks from viral sequences collected as part of HIV surveillance in New York City, Los Angeles County, and Cook County, Illinois. We calculated assortativity (the tendency for individuals to link to others with similar characteristics) across the network for three candidate characteristics: transmission risk, age at diagnosis, and race/ethnicity. We then compared assortativity between race/ethnicity groups. Finally, for each race/ethnicity pair, we performed network permutations to test whether the number of links observed differed from that expected if individuals were sorting at random. Transmission...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5jq8x528</guid>
      <pubDate>Thu, 15 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Ragonnet-Cronin, Manon</name>
      </author>
      <author>
        <name>Benbow, Nanette</name>
      </author>
      <author>
        <name>Hayford, Christina</name>
      </author>
      <author>
        <name>Poortinga, Kathleen</name>
      </author>
      <author>
        <name>Ma, Fangchao</name>
      </author>
      <author>
        <name>Forgione, Lisa A</name>
      </author>
      <author>
        <name>Sheng, Zhijuan</name>
      </author>
      <author>
        <name>Hu, Yunyin W</name>
      </author>
      <author>
        <name>Torian, Lucia V</name>
      </author>
      <author>
        <name>Wertheim, Joel O</name>
      </author>
    </item>
    <item>
      <title>Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells</title>
      <link>https://escholarship.org/uc/item/6k89382t</link>
      <description>Latent HIV infection is the main barrier to cure, and most HIV-infected cells reside in the gut, where distinct but unknown mechanisms may promote viral latency. Transforming growth factor β (TGF-β), which induces the expression of CD103 on tissue-resident memory T cells, has been implicated in HIV latency. Using CD103 as a surrogate marker to identify cells that have undergone TGF-β signaling, we compared the HIV RNA/DNA contents and cellular transcriptomes of CD103&lt;sup&gt;+&lt;/sup&gt; and CD103&lt;sup&gt;-&lt;/sup&gt; CD4 T cells from the blood and rectum of HIV-negative (HIV&lt;sup&gt;-&lt;/sup&gt;) and antiretroviral therapy (ART)-suppressed HIV-positive (HIV&lt;sup&gt;+&lt;/sup&gt;) individuals. Like gut CD4&lt;sup&gt;+&lt;/sup&gt; T cells, circulating CD103&lt;sup&gt;+&lt;/sup&gt; cells harbored more HIV DNA than did CD103&lt;sup&gt;-&lt;/sup&gt; cells but transcribed less HIV RNA per provirus. Circulating CD103&lt;sup&gt;+&lt;/sup&gt; cells also shared a gene expression profile that is closer to that of gut CD4 T cells than to that of circulating CD103&lt;sup&gt;-&lt;/sup&gt;...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6k89382t</guid>
      <pubDate>Tue, 13 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Yukl, Steven A</name>
      </author>
      <author>
        <name>Khan, Shahzada</name>
      </author>
      <author>
        <name>Chen, Tsui-Hua</name>
      </author>
      <author>
        <name>Trapecar, Martin</name>
      </author>
      <author>
        <name>Wu, Frank</name>
      </author>
      <author>
        <name>Xie, Guorui</name>
      </author>
      <author>
        <name>Telwatte, Sushama</name>
      </author>
      <author>
        <name>Fulop, Daniel</name>
      </author>
      <author>
        <name>Pico, Alexander R</name>
      </author>
      <author>
        <name>Laird, Gregory M</name>
      </author>
      <author>
        <name>Ritter, Kristen D</name>
      </author>
      <author>
        <name>Jones, Norman G</name>
      </author>
      <author>
        <name>Lu, Chuanyi M</name>
        <uri>https://orcid.org/0000-0002-5906-2543</uri>
      </author>
      <author>
        <name>Siliciano, Robert F</name>
      </author>
      <author>
        <name>Roan, Nadia R</name>
      </author>
      <author>
        <name>Milush, Jeffrey M</name>
      </author>
      <author>
        <name>Somsouk, Ma</name>
        <uri>https://orcid.org/0000-0001-6116-3645</uri>
      </author>
      <author>
        <name>Deeks, Steven G</name>
      </author>
      <author>
        <name>Hunt, Peter W</name>
      </author>
      <author>
        <name>Sanjabi, Shomyseh</name>
      </author>
    </item>
    <item>
      <title>Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study</title>
      <link>https://escholarship.org/uc/item/55473447</link>
      <description>BACKGROUND: Sex hormone and preexposure prophylaxis (PrEP) drug interactions among transgender women (TGW), transgender men (TGM), and cisgender men (CGM) are not fully understood.
METHODS: TGM and TGW on at least 6 months of stable sex hormone therapy containing testosterone or estradiol (respectively) were enrolled in a 4-week study of directly observed dosing of daily oral coformulated emtricitabine and tenofovir disoproxil fumarate (FTC/TDF). TFV-DP in dried blood spots and sex hormones in serum were measured at weekly intervals. TFV-DP was compared with 2- and 4-week samples from Directly Observed Therapy Dried Blood Spots (DOT-DBS) Study (NCT02022657).
RESULTS: From May 2017 to June 2018, 24 TGM and 24 TGW were enrolled. Testosterone (total and free) and estradiol concentrations were comparable before and after 4 weeks of PrEP use in TGM and TGW, respectively. Historical controls included 17 cisgender women (CGW) and 15 CGM. TFV-DP concentrations at week 4 were comparable...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/55473447</guid>
      <pubDate>Sat, 10 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Grant, Robert M</name>
      </author>
      <author>
        <name>Pellegrini, Marion</name>
      </author>
      <author>
        <name>Defechereux, Patricia A</name>
      </author>
      <author>
        <name>Anderson, Peter L</name>
      </author>
      <author>
        <name>Yu, Michelle</name>
      </author>
      <author>
        <name>Glidden, David V</name>
        <uri>https://orcid.org/0000-0001-5888-1419</uri>
      </author>
      <author>
        <name>O’Neal, Joshua</name>
      </author>
      <author>
        <name>Yager, Jenna</name>
      </author>
      <author>
        <name>Bhasin, Shalender</name>
      </author>
      <author>
        <name>Sevelius, Jae</name>
      </author>
      <author>
        <name>Deutsch, Madeline B</name>
      </author>
    </item>
    <item>
      <title>Development of a measure to assess vaccine confidence among men who have sex with men</title>
      <link>https://escholarship.org/uc/item/0s48b953</link>
      <description>BACKGROUND: Recent serogroup C meningococcal disease outbreaks led to meningococcal vaccine recommendations for Southern California men who have sex with men (MSM). Assessment of vaccine confidence is critical to improving vaccine coverage in the context of disease outbreaks wherein immunization(s) are recommended.
METHODS: We surveyed MSM using venue-based sampling and began development of the vaccine confidence index (VCI) with 30 survey items corresponding to trust- and safety-related perceptions. We performed exploratory factor analyses and computed the Cronbach's alpha coefficient to assess internal consistency of the VCI. We created a categorical confidence variable (low, medium, and high confidence) and conducted bivariate and multivariate analyses to evaluate associations with reported confidence and immunization uptake.
RESULTS: Ten survey items were included in the final VCI and formed the confidence measure. Participants with low confidence had the lowest levels of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0s48b953</guid>
      <pubDate>Sat, 3 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Frew, Paula M</name>
      </author>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Goldbeck, Cameron</name>
      </author>
      <author>
        <name>Tan, Diane</name>
      </author>
      <author>
        <name>Wu, Elizabeth</name>
      </author>
      <author>
        <name>Jauregui, Juan</name>
      </author>
      <author>
        <name>Fenimore, Vincent L</name>
      </author>
      <author>
        <name>Randall, Laura A</name>
      </author>
      <author>
        <name>Lutz, Chelsea S</name>
      </author>
      <author>
        <name>Mendel, Judith</name>
      </author>
      <author>
        <name>Aikin, Ann L</name>
      </author>
      <author>
        <name>Nowak, Glen J</name>
      </author>
      <author>
        <name>Bednarczyk, Robert A</name>
      </author>
    </item>
    <item>
      <title>Concomitant Utilization of Pre-Exposure Prophylaxis (PrEP) and Meningococcal Vaccine (MenACWY) Among Gay, Bisexual, and Other Men Who Have Sex with Men in Los Angeles County, California</title>
      <link>https://escholarship.org/uc/item/3wp9f2c2</link>
      <description>Recent outbreaks of serogroup C meningococcal disease in Southern California have led the California Department of Public Health to recommend the quadrivalent meningococcal vaccine (MenACWY) for gay, bisexual, and other men who have sex with men (GBMSM) in Southern California. High-risk GBMSM have also been advised to utilize pre-exposure prophylaxis (PrEP) for HIV prevention. Data collected from a community-based sample of HIV-negative GBMSM in Los Angeles County (N = 476) were used in a multinomial logit regression analysis to identify patterns in MenACWY and PrEP usage and evaluate factors associated with use of both, one, or neither of these prevention methods. More than half (56%) of participants had neither been vaccinated nor used PrEP. A smaller percentage (34%) had either been vaccinated or were PrEP users, leaving 10% who had concomitant PrEP and MenACWY use. Higher education, more recent sex partners, illicit drug use, and recent receptive condomless anal sex (CAS)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3wp9f2c2</guid>
      <pubDate>Fri, 2 Jun 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Tan, Diane</name>
      </author>
      <author>
        <name>Bednarczyk, Robert A</name>
      </author>
      <author>
        <name>Fenimore, Vincent L</name>
      </author>
      <author>
        <name>Randall, Laura</name>
      </author>
      <author>
        <name>Lutz, Chelsea S</name>
      </author>
      <author>
        <name>Frew, Paula M</name>
      </author>
    </item>
    <item>
      <title>Perspectives on Academic Mentorship From Sexual and Gender Minority Students Pursuing Careers in the Health Sciences</title>
      <link>https://escholarship.org/uc/item/4wc246w1</link>
      <description>High-quality academic mentorship is key to the success of students pursuing careers in the health sciences. Mentorship may take on additional importance for sexual and gender minority (SGM) students, who often face stressors related to stigmatized identities. We conducted an anonymous online survey to assess the mentorship experiences of SGM students pursuing careers in the health sciences and to elicit their perspectives on what makes an effective mentor. Students (N = 166) were pursuing a variety of health-related careers, including medicine (12.7%), nursing (7.8%), public health (21.1%), and social work (19.3%). Overall, students rated the quality of their mentorship experiences as (very) good: 83.8% among participants who reported having had an academic mentor that openly identified as SGM and 79.5% among participants who had a non-SGM identified mentor (ns). Participants recommended individual, dyadic and structural level activities that could be undertaken by academic mentors...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4wc246w1</guid>
      <pubDate>Mon, 29 May 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Holloway, Ian W</name>
      </author>
      <author>
        <name>Ochoa, Ayako Miyashita</name>
      </author>
      <author>
        <name>Wu, Elizabeth SC</name>
      </author>
      <author>
        <name>Himmelstein, Rebecca</name>
      </author>
      <author>
        <name>Wong, Jeffrey O</name>
      </author>
      <author>
        <name>Wilson, Bianca DM</name>
        <uri>https://orcid.org/0000-0001-5842-5229</uri>
      </author>
    </item>
    <item>
      <title>HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis</title>
      <link>https://escholarship.org/uc/item/4h396321</link>
      <description>HIV pre-exposure prophyalxis (PrEP) might lead individuals to view serodisclosure as unnecessary. We examined the prevalence of non-disclosure and lack of knowledge of partner status in a global cohort of men who have sex with men (MSM) and transgender women (TW) enrolled in the iPrEx Open Label Extension (OLE). We calculated prevalence ratios by fitting a logistic model and estimating predicted probabilities using marginal standardization. Prevalence of non-disclosure and lack of knowledge of partner status were highest in Thailand (73% and 74%, respectively) and lowest in the USA (23% and 37%, respectively). In adjusted analyses, PrEP use was not significantly associated with non-disclosure or lack of knowledge of partner status (p-values&amp;gt;0.05). We found that relationship characteristics were significantly associated with both outcomes. Non-disclosure was higher among casual (adjusted prevalence ratio [aPR] 1.54, [95% confidence interval 1.24-1.84]) and transactional sex...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4h396321</guid>
      <pubDate>Mon, 15 May 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Hojilla, J Carlo</name>
      </author>
      <author>
        <name>Mehrotra, Megha</name>
      </author>
      <author>
        <name>Truong, Hong-Ha M</name>
      </author>
      <author>
        <name>Glidden, David V</name>
        <uri>https://orcid.org/0000-0001-5888-1419</uri>
      </author>
      <author>
        <name>Amico, K Rivet</name>
      </author>
      <author>
        <name>McMahan, Vanessa</name>
      </author>
      <author>
        <name>Vlahov, David</name>
      </author>
      <author>
        <name>Chariyalertsak, Suwat</name>
      </author>
      <author>
        <name>Guanira, Juan Vicente</name>
      </author>
      <author>
        <name>Grant, Robert M</name>
      </author>
      <author>
        <name>team, for the iPrEx study</name>
      </author>
    </item>
    <item>
      <title>Depletion of Gut-Resident CCR5+ Cells for HIV Cure Strategies</title>
      <link>https://escholarship.org/uc/item/3b19706g</link>
      <description>The HIV reservoir forming at the earliest stages of infection is likely composed of CCR5&lt;sup&gt;+&lt;/sup&gt; cells, because these cells are the targets of transmissible virus. Restriction of the CCR5&lt;sup&gt;+&lt;/sup&gt; reservoir, particularly in the gut, may be needed for subsequent cure attempts. Strategies for killing or depleting CCR5&lt;sup&gt;+&lt;/sup&gt; cells have been described, but none have been tested in vivo in nonhuman primates, and the extent of achievable depletion from tissues is not known. In this study we investigate the efficacy of two novel cytotoxic treatments for targeting and eliminating CCR5&lt;sup&gt;+&lt;/sup&gt; cells in young rhesus macaques. The first, an immunotoxin consisting of the endogenous CCR5 ligand RANTES fused with Pseudomonas exotoxin (RANTES-PE38), killed CCR5&lt;sup&gt;+&lt;/sup&gt; lamina propria lymphocytes (LPLs) ex vivo, but had no detectable effect on CCR5&lt;sup&gt;+&lt;/sup&gt; LPLs in vivo. The second, a primatized bispecific antibody for CCR5 and CD3, depleted all CCR5&lt;sup&gt;+&lt;/sup&gt; cells...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3b19706g</guid>
      <pubDate>Sat, 13 May 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Merriam, David</name>
      </author>
      <author>
        <name>Chen, Connie</name>
      </author>
      <author>
        <name>Méndez-Lagares, Gema</name>
      </author>
      <author>
        <name>Rogers, Kenneth A</name>
      </author>
      <author>
        <name>Michaels, Anthony J</name>
      </author>
      <author>
        <name>Yan, Jiangli</name>
      </author>
      <author>
        <name>Casaz, Paul</name>
      </author>
      <author>
        <name>Reimann, Keith A</name>
      </author>
      <author>
        <name>Villinger, François</name>
      </author>
      <author>
        <name>Hartigan-O'Connor, Dennis J</name>
      </author>
    </item>
    <item>
      <title>“I feel like marijuana is the only drug that wouldn’t kill me”: perceptions of cannabis use in previously incarcerated Black men who have sex with other men</title>
      <link>https://escholarship.org/uc/item/9dv5109s</link>
      <description>BackgroundFragmented state laws have impacted cannabis uptake and perceptions in the USA. Little research has explored the attitudes, beliefs, and social network influences of young Black men who have sex with men (BMSM) who have experienced incarceration and use cannabis. While problematic cannabis use is not well defined and understudied, scholars have found that a person’s social network can mediate problematic substance use and reduce recidivism rates by providing both tangible and emotional support. This analysis examines how social networks contribute to cannabis perceptions and use among BMSM with criminal legal system involvement in Chicago, IL, and Houston TX.
MethodsResearchers conducted interviews with 25 cis gender Black men informed by life course theory, with a focus on the role of social networks, incarceration, and other life experiences in substance use. All interviews were audio-recorded, de-identified, and transcribed; participants were compensated $50. A deductive-inductive...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9dv5109s</guid>
      <pubDate>Sun, 19 Mar 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Flores, Rey</name>
      </author>
      <author>
        <name>Kerman, Jared</name>
      </author>
      <author>
        <name>Schneider, John</name>
      </author>
      <author>
        <name>Harawa, Nina</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Low incidence and prevalence of hepatitis C in two cohorts of HIV pre‐exposure prophylaxis adherence interventions in men who have sex with men in Southern California</title>
      <link>https://escholarship.org/uc/item/2wc3f2cn</link>
      <description>HIV pre-exposure prophylaxis (PrEP) has been associated with incident hepatitis C virus (HCV) infection in men who have sex with men (MSM) due to decreased condom use. We examined rates of HCV among MSM and transgender women at high-risk of HIV on PrEP in Southern California using data from two trials (NCT01761643 and NCT01781806). Five of 599 participants (0.84%, 95% CI, 0.27-1.93) had HCV antibodies detected at entry. Factors associated with HCV seropositivity included being older (p&amp;nbsp;=&amp;nbsp;.002) and lower education level (p&amp;nbsp;&amp;lt;&amp;nbsp;.001). HCV-positive participants had no reported cases of sexually transmitted infection (rectal, urethral or pharyngeal gonorrhoea and/or chlamydia) at entry while HCV-negative participants had a prevalence of 18% (95% CI, 15%-21%). There were no significant differences in substance use and sexual risk behaviour between HCV-positive and HCV-negative participants 1-3&amp;nbsp;months prior to entry. Among early PrEP adopters, incident HCV...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2wc3f2cn</guid>
      <pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate>
      <author>
        <name>Hassan, Adiba</name>
      </author>
      <author>
        <name>San Agustin, Harold Glenn</name>
      </author>
      <author>
        <name>Burke, Leah</name>
        <uri>https://orcid.org/0000-0001-8220-3263</uri>
      </author>
      <author>
        <name>Kofron, Ryan</name>
      </author>
      <author>
        <name>Corado, Katya</name>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
      <author>
        <name>Dubé, Michael P</name>
      </author>
      <author>
        <name>Morris, Sheldon R</name>
      </author>
    </item>
    <item>
      <title>A qualitative study of antiretroviral therapy adherence interruptions among young Latino men who have sex with men with HIV: Project D.A.I.L.Y.</title>
      <link>https://escholarship.org/uc/item/30x7r7gc</link>
      <description>Consistent antiretroviral therapy (ART) adherence is necessary for HIV viral suppression. However, adherence may fluctuate around daily routines and life events, warranting intervention support. We examined reasons for ART adherence interruptions, using in-depth, semi-structured qualitative interviews, among young (18-34-year-old) Latino men who have sex with men (YLMSM) with HIV. Interviews (&lt;i&gt;n&lt;/i&gt; = 24) were guided by the Theory of Planned Behavior, the Information-Motivation-Behavioral Skills Theory, and the Socio-Ecological Model. Two coders independently coded transcripts using NVivo 12 software and synthesized codes into themes using Thematic Content Analysis. Results suggested 4 primary influences on ART adherence interruptions: (1) HIV diagnosis denial, (2) breaks in daily routine, (3) substance use, and (4) HIV status disclosure. Participant quotes highlighted routinization of pill-taking and planning ahead for breaks in routine as critically important. The narrative...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/30x7r7gc</guid>
      <pubDate>Thu, 15 Dec 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Sheehan, Diana M</name>
      </author>
      <author>
        <name>De La Cruz, Yazmine</name>
      </author>
      <author>
        <name>Ramírez-Ortiz, Daisy</name>
      </author>
      <author>
        <name>Swendeman, Dallas</name>
        <uri>https://orcid.org/0000-0002-4570-6352</uri>
      </author>
      <author>
        <name>Muñoz-Laboy, Miguel</name>
      </author>
      <author>
        <name>Duncan, Dustin T</name>
      </author>
      <author>
        <name>Cano, Miguel Ángel</name>
      </author>
      <author>
        <name>Devieux, Jessy G</name>
      </author>
      <author>
        <name>Trepka, Mary Jo</name>
      </author>
    </item>
    <item>
      <title>Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study</title>
      <link>https://escholarship.org/uc/item/3p06p852</link>
      <description>BACKGROUND: Transgender and nonbinary individuals at risk for HIV may benefit from adherence support for pre-exposure prophylaxis.
METHODS: Between June 2017 and September 2020, 255 transgender and nonbinary individuals received daily oral tenofovir disoproxil fumarate/emtricitabine for 48 weeks randomized 1:1 to receive individualized Texting for Adherence Building (iTAB) or iTAB plus motivational interviewing (iTAB + MI) through phone for nonadherence. The primary end point was dried blood spot tenofovir diphosphate concentrations at weeks 12 and 48 (or last on-drug study visit) ≥1246 fmol/punch consistent with ≥7 doses/week (ie, near-perfect adherence). Secondary outcomes included dried blood spot tenofovir diphosphate concentrations ≥719 fmol/punch consistent with ≥4 doses/week (ie, adequate adherence) and self-reported adherence by daily text messages.
RESULTS: Adherence for the outcome ≥1246 fmol/punch and ≥719 fmol/punch, respectively, was 49.1% and 57.9% for transgender...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3p06p852</guid>
      <pubDate>Wed, 16 Nov 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Morris, Sheldon R</name>
      </author>
      <author>
        <name>Jain, Sonia</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Dubé, Michael P</name>
      </author>
      <author>
        <name>Henderson, Philip</name>
      </author>
      <author>
        <name>Corado, Katya</name>
      </author>
      <author>
        <name>Sun, Shelly</name>
      </author>
      <author>
        <name>He, Feng</name>
      </author>
      <author>
        <name>Chow, Karen</name>
      </author>
      <author>
        <name>Burke, Leah</name>
        <uri>https://orcid.org/0000-0001-8220-3263</uri>
      </author>
      <author>
        <name>Anderson, Peter L</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
    </item>
    <item>
      <title>Impacts of COVID-19 on HIV/AIDS-Related Services in California.</title>
      <link>https://escholarship.org/uc/item/71m42268</link>
      <description>&lt;p&gt;The degree to which COVID-19 has disrupted the advances in reducing new HIV infections and preventing AIDS-related deaths is unknown. We present findings related to the effect COVID-19 had on HIV, sexual health and harm reduction service delivery in the state of California. We conducted a qualitative rapid assessment with health care providers, as well as representatives from non-medical support service agencies serving clients living with HIV in a range of counties in California. Some organizations adapted fairly easily while others struggled or were unable to adapt at all. Clinics were better positioned than community-based organizations to accommodate COVID restrictions and to quickly reestablish services. Influential forces that softened or calcified the hardships created by COVID-19 included influx of funding, flexibility in managing funds, networking and relationships, and workforce vulnerabilities. These data clearly suggest that an enhanced level of flexibility within...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/71m42268</guid>
      <pubDate>Tue, 1 Nov 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Koester, Kimberly A</name>
      </author>
      <author>
        <name>Fuller, Shannon M</name>
      </author>
      <author>
        <name>Steward, Wayne T</name>
      </author>
      <author>
        <name>Arnold, Emily A</name>
      </author>
    </item>
    <item>
      <title>RETRACTED: Developing Android, iOS Apps for Mobile-Enhanced Prevention Support (MEPS) for Men Who Have Sex with Men (MSM) and Transgender Women (TW) Leaving Jail in South Los Angeles in the USA</title>
      <link>https://escholarship.org/uc/item/6mv7q9mn</link>
      <description>This article has been withdrawn from publication at the request of the second and third author, Dr. Edwards and Dr. Harawa.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6mv7q9mn</guid>
      <pubDate>Thu, 27 Oct 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Mukherjee, Sukrit</name>
      </author>
      <author>
        <name>Edwards, Gabriel G</name>
      </author>
      <author>
        <name>Harawa, Nina</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California</title>
      <link>https://escholarship.org/uc/item/1s24164h</link>
      <description>People who inject drugs (PWID) have extraordinarily low uptake of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) despite high levels of need. Long-acting PrEP modalities hold promise for HIV prevention among PWID, but product preferences remain poorly understood. From September to November 2021, we conducted qualitative interviews with 28 HIV-negative, adult (≥18 years) PWID in San Diego County, CA, to explore their perspectives on daily oral PrEP pills and long-acting PrEP modalities (i.e., injections, implants, intravaginal rings, and broadly neutralizing antibodies), which we explained using standard scripts. Thematic analysis identified variations in PrEP modality interest and acceptability. We identified three key factors across the 28 interviews that appeared to influence PrEP modality preferences: perceived convenience of use, invasiveness, and familiarity (based on past experience). Overall, most participants preferred injectable PrEP over other modalities...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1s24164h</guid>
      <pubDate>Thu, 27 Oct 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Bazzi, Angela R</name>
        <uri>https://orcid.org/0000-0001-6828-1919</uri>
      </author>
      <author>
        <name>Valasek, Chad J</name>
      </author>
      <author>
        <name>Streuli, Samantha A</name>
      </author>
      <author>
        <name>Vera, Carlos F</name>
      </author>
      <author>
        <name>Harvey-Vera, Alicia</name>
      </author>
      <author>
        <name>Philbin, Morgan M</name>
      </author>
      <author>
        <name>Biello, Katie B</name>
      </author>
      <author>
        <name>Roth, Alexis M</name>
      </author>
      <author>
        <name>Strathdee, Steffanie A</name>
      </author>
      <author>
        <name>Pines, Heather A</name>
      </author>
    </item>
    <item>
      <title>Relating ‘to her Human Side’: a Grounded Theory analysis of cosmetologists’ and aestheticians’ relationships with clients in Black American beauty salons to inform sexual health interventions</title>
      <link>https://escholarship.org/uc/item/13v7744p</link>
      <description>Due to the elevated incidence of HIV among Black American women, effective sexual health interventions are needed. To explore beauty salons as settings for such interventions, we examined Black American women stylists' experiences discussing sex-related topics with Black American women clients. Constructivist Grounded Theory methodology guided data collection and analysis. Individual intensive interviews were conducted in 2019 with 16 Black women cosmetologists and/or aestheticians who served Black women in Southern California. Analyses generated grounded theory which we refer to as Relating 'to her Human Side': Black American cosmetologist-client relationship building model. The model highlights the importance of three sets of practices: 1) playing different roles to appeal to clients' varying wants and needs, 2) creating a comfortable atmosphere, and 3) establishing a judgement-free zone. Stylists put clients at ease and consequently, clients shared stories regarding sex and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/13v7744p</guid>
      <pubDate>Thu, 27 Oct 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Morehead-Gee, Alicia</name>
      </author>
      <author>
        <name>Üsküp, Dilara K</name>
      </author>
      <author>
        <name>Omokaro, Uwaila</name>
      </author>
      <author>
        <name>Shoptaw, Steve</name>
        <uri>https://orcid.org/0000-0002-3583-0026</uri>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Heilemann, MarySue V</name>
      </author>
    </item>
    <item>
      <title>Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine</title>
      <link>https://escholarship.org/uc/item/9r46v03f</link>
      <description>Long-acting injectable antiretroviral medications are new to HIV treatment. People with HIV may benefit from a treatment option that better aligns with their preferences, but could also face new challenges and barriers. Authors from the fields of HIV, substance use treatment, and mental health collaborated on this commentary on the issues surrounding equitable implementation and uptake of LAI ART by drawing lessons from all three fields. We employ a socio-ecological framework beginning at the policy level and moving through the community, organizational, interpersonal, and patient levels. We look at extant literature on the topic as well as draw from the direct experience of our clinician-authors.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9r46v03f</guid>
      <pubDate>Wed, 26 Oct 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Edwards, Gabriel G</name>
        <uri>https://orcid.org/0000-0002-1083-0919</uri>
      </author>
      <author>
        <name>Miyashita-Ochoa, Ayako</name>
      </author>
      <author>
        <name>Castillo, Enrico G</name>
      </author>
      <author>
        <name>Goodman-Meza, David</name>
      </author>
      <author>
        <name>Kalofonos, Ippolytos</name>
      </author>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
      <author>
        <name>Leibowitz, Arleen A</name>
        <uri>https://orcid.org/0000-0001-6970-0564</uri>
      </author>
      <author>
        <name>Pulsipher, Craig</name>
      </author>
      <author>
        <name>El Sayed, Ed</name>
      </author>
      <author>
        <name>Shoptaw, Steven</name>
        <uri>https://orcid.org/0000-0002-3583-0026</uri>
      </author>
      <author>
        <name>Shover, Chelsea L</name>
      </author>
      <author>
        <name>Tabajonda, Michelle</name>
      </author>
      <author>
        <name>Yang, Yvonne S</name>
        <uri>https://orcid.org/0000-0001-8581-0624</uri>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Facilitators of PrEP Persistence among Black and Latinx Transgender Women in a PrEP Demonstration Project in Southern California</title>
      <link>https://escholarship.org/uc/item/9j25f5zd</link>
      <description>Black and Latinx transgender women in the United States (U.S.) are at disproportionately high risk for HIV. Although HIV pre-exposure prophylaxis (PrEP) reduces the risk of HIV infection, uptake and persistence (i.e., ability to continue taking PrEP over time) can be a challenge for Black and Latinx transgender women due to myriad social and structural forces. In this qualitative study, we present unique data on the facilitators of PrEP persistence from Black and Latinx transgender women who initiated PrEP and exhibited varying levels of persistence during a demonstration project in Southern California. PrEP persistence was assessed by collecting quantitative intracellular tenofovir-diphosphate (TFV-DP) levels on dried blood spot (DBS) samples collected at weeks 12 and 48. Informed by the socioecological framework, we conducted and analyzed interviews using qualitative content analysis to determine themes on the facilitators of PrEP persistence. Individual-level facilitators included...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9j25f5zd</guid>
      <pubDate>Wed, 21 Sep 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Storholm, Erik D</name>
      </author>
      <author>
        <name>Ogunbajo, Adedotun</name>
      </author>
      <author>
        <name>Nacht, Carrie L</name>
      </author>
      <author>
        <name>Opalo, Chloe</name>
      </author>
      <author>
        <name>Horvath, Keith J</name>
      </author>
      <author>
        <name>Lyman, Phoebe</name>
      </author>
      <author>
        <name>Flynn, Risa</name>
      </author>
      <author>
        <name>Reback, Cathy J</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
    </item>
    <item>
      <title>Gender-Based Violence and Post-traumatic Stress Disorder Symptoms Predict HIV PrEP Uptake and Persistence Failure Among Transgender and Non-binary Persons Participating in a PrEP Demonstration Project in Southern California</title>
      <link>https://escholarship.org/uc/item/7ts2q6n0</link>
      <description>Gender-based violence (GBV) against transgender and nonbinary (TGNB) persons is a pervasive public health issue. GBV has been linked to mental health problems such as depression and posttraumatic stress disorder (PTSD), as well has risk for HIV seroconversion and HIV treatment nonadherence. However, the impact of GBV on HIV pre-exposure prophylaxis (PrEP) use among TGNB persons has yet to be investigated. In the current study we assessed longitudinal PrEP persistence data from dried blood spots (DBS) collected from 172 racially and ethnically diverse TGNB participants during a 48-week PrEP demonstration project in Southern California from June 2017 to September 2020. Participants were categorized into three levels of PrEP uptake and persistence based on their PrEP levels at the start and end of the study: low–low, high–low, and high–high. Individual-, social-, and structural-level variables were then entered into multinomial logistic regression models to predict levels of PrEP...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7ts2q6n0</guid>
      <pubDate>Wed, 21 Sep 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Storholm, Erik D</name>
      </author>
      <author>
        <name>Huang, Wenjing</name>
      </author>
      <author>
        <name>Ogunbajo, Adedotun</name>
      </author>
      <author>
        <name>Horvath, Keith J</name>
      </author>
      <author>
        <name>Reback, Cathy J</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Flynn, Risa P</name>
      </author>
      <author>
        <name>Bolan, Robert K</name>
      </author>
      <author>
        <name>Corado, Katya C</name>
      </author>
      <author>
        <name>Morris, Sheldon R</name>
      </author>
    </item>
    <item>
      <title>Factors associated with HIV testing and treatment among young Black MSM and trans women in three jail systems</title>
      <link>https://escholarship.org/uc/item/39v576s2</link>
      <description>Black men who have sex with men (BMSM) and transgender women (BTW) are disproportionately affected by incarceration and HIV. We assessed factors associated with HIV testing and viral suppression among 176 incarcerated BMSM and BTW in Chicago, IL; Los Angeles, CA; and Houston, TX. In multivariable logistic regression, having a sexual orientation of bisexual, heterosexual, or other vs. gay or same-gender loving was associated with higher odds of testing in custody (aOR 8.97; 95% CI 1.95 - 41.24). Binge drinking (aOR 0.19; 95% CI 0.04 - 0.92) and being unemployed prior to incarceration (aOR 0.03; 95% CI 0.00 - 0.23) were associated with lower odds of testing; participants in Los Angeles were also more likely to be tested than those in Chicago. Being housed in protective custody (aOR 3.12; 95% CI 1.09-9.59) and having a prescription for ART prior to incarceration (aOR 2.58; 95% CI 1.01-6.73) were associated with higher odds of viral suppression when adjusted for site and duration...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/39v576s2</guid>
      <pubDate>Thu, 15 Sep 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Antos, Nicholas</name>
      </author>
      <author>
        <name>Flores, Rey</name>
      </author>
      <author>
        <name>Harawa, Nina</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Del Vecchio, Natascha</name>
      </author>
      <author>
        <name>Issema, Rodal</name>
      </author>
      <author>
        <name>Fujimoto, Kayo</name>
      </author>
      <author>
        <name>Khanna, Aditya S</name>
      </author>
      <author>
        <name>Di Paola, Angela</name>
      </author>
      <author>
        <name>Schneider, John A</name>
      </author>
      <author>
        <name>Hotton, Anna L</name>
      </author>
    </item>
    <item>
      <title>Evidence for the Role of State-Level Economic Policy in HIV Risk Reduction: State Earned Income Tax Credit Generosity and HIV Risk Behavior Among Single Mothers</title>
      <link>https://escholarship.org/uc/item/3420s1xw</link>
      <description>We investigated the impact of State-level Earned Income Tax Credit (SEITC) generosity on HIV risk behavior among single mothers with low education. We merged individual-level data from the Behavioral Risk Factor Surveillance System (2002–2018) with state-level data from the University of Kentucky Center for Poverty Research and conducted a multi-state, multi-year difference-in-differences (DID) analysis. We found that a refundable SEITC ≥ 10% of the Federal Earned Income Tax Credit was associated with 21% relative risk reduction in reporting any high-risk behavior for HIV in the last year, relative to no SEITC. We also found that a 10-percentage point increase in SEITC generosity was associated with 38% relative risk reduction in reporting any high-risk HIV behavior in the last year. SEITC policy may be an important strategy to reduce the burden of HIV infections among women with low socioeconomic status, particularly single mothers.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3420s1xw</guid>
      <pubDate>Thu, 15 Sep 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Narain, Kimberly Danae Cauley</name>
      </author>
      <author>
        <name>Harawa, Nina</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Using social and sexual networking mobile applications to promote HIV testing, medical care and prevention services among Latino men who have sex with men in Los Angeles County, California, USA</title>
      <link>https://escholarship.org/uc/item/18n6d50c</link>
      <description>HIV disproportionately affects Latinos versus Whites, with Latinos having higher rates of HIV. Additionally, many HIV-positive Latinos are unaware of their infection. Proyecto Protégete, an HIV prevention intervention developed for Latino men who have sex with men (MSM), used social and sexual networking mobile applications (apps) to recruit individuals for HIV testing and linkage to medical care and prevention services. This study occurred in Los Angeles County, California, USA from December 18, 2015 to April 22, 2017. The study's primary aim was to assess Proyecto Protégete's ability to successfully recruit Latino MSM involved in high-risk sexual activities. A secondary aim was to evaluate its capacity to promote HIV testing and linkage to HIV medical care and prevention services among this population by comparing it to two programs with similar samples. Comparisons using Fisher's Exact Test were conducted between Proyecto Protégete and the HIV testing program of the agency...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/18n6d50c</guid>
      <pubDate>Tue, 30 Aug 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Galvan, Frank H</name>
      </author>
      <author>
        <name>Liu, Honghu</name>
      </author>
      <author>
        <name>Brooks, Ronald A</name>
      </author>
      <author>
        <name>Chen, Ying-Tung</name>
      </author>
      <author>
        <name>Lepe, Ricardo Mendoza</name>
      </author>
    </item>
    <item>
      <title>Method of Calculating Renal Function Estimates Could Inappropriately Exclude Transgender Patients Receiving Gender-Affirming Hormone Therapy from Pre-Exposure Prophylaxis Eligibility</title>
      <link>https://escholarship.org/uc/item/43k985pp</link>
      <description>&lt;b&gt;&lt;i&gt;Purpose:&lt;/i&gt;&lt;/b&gt; Despite the importance of reliable renal function estimation among the growing transgender population, research describing the variability of existing equations is scarce. Study objectives were to (1) quantify the range of renal function estimates that would be observed if different gender coefficients are used in the estimating equations, (2) compare estimates of renal function (creatinine clearance [CL&lt;sub&gt;CR&lt;/sub&gt;] or estimated glomerular filtration rate [GFR]) between users and nonusers of gender-affirming therapies, and (3) quantify the proportion of subjects who would be deemed ineligible for tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis (PrEP) based on the gender coefficient used. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; A retrospective analysis was performed among transgender PrEP users enrolled in a multicenter observational study between June 2017 and October 2021. The primary outcome was estimated kidney function, defined using...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/43k985pp</guid>
      <pubDate>Tue, 23 Aug 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Patel, Nimish</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Dubé, Michael P</name>
      </author>
      <author>
        <name>Hood, Allison</name>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
    </item>
    <item>
      <title>Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial.</title>
      <link>https://escholarship.org/uc/item/5sc8n8fv</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;People living with HIV (PLWH) often experience decreases in HIV viral suppression (VS) after release from jail. The Linking Inmates to Care in LA (LINK LA) peer navigation intervention helped maintain VS 12 months after release from jail compared to standard of care. In this study, we analyzed correlates of substance use and tested whether substance use was an independent correlate of decreased VS in LINK LA participants.&lt;h4&gt;Methods&lt;/h4&gt;We analyzed LINK LA data collected at baseline, 3, and 12 months. We defined high-risk drug use as any reported methamphetamine, cocaine, or opioid use in the 30 days prior to a study visit (or jail entry at baseline). We used generalized linear mixed models to test associations of sociodemographic variables with type of substance used, and we tested correlates of VS while controlling for time, the intervention, and their interaction.&lt;h4&gt;Results&lt;/h4&gt;At baseline (n = 356), 71% of participants reported high-risk drug use: 58%,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5sc8n8fv</guid>
      <pubDate>Thu, 28 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Goodman-Meza, David</name>
      </author>
      <author>
        <name>Shoptaw, Steve</name>
        <uri>https://orcid.org/0000-0002-3583-0026</uri>
      </author>
      <author>
        <name>Weiss, Robert E</name>
        <uri>https://orcid.org/0000-0003-3648-8522</uri>
      </author>
      <author>
        <name>Nakazono, Terry</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Takada, Sae</name>
      </author>
      <author>
        <name>Garland, Wendy H</name>
      </author>
      <author>
        <name>Cunningham, William E</name>
      </author>
    </item>
    <item>
      <title>“Being downcast by society… adds to the stress levels and would explain why [we] smoke more.”: Smoking among HIV-positive Black men who have sex with men</title>
      <link>https://escholarship.org/uc/item/8qw107sx</link>
      <description>Smoking causes more deaths among people living with HIV than HIV infection itself. Few smoking cessation interventions and studies of sexual minority communities have considered the lived experiences of Black men who have sex with men (BMSM) living with HIV. Before developing interventions for these men, we need to answer: How do experiences of discrimination and stigma influence their perceptions of smoking? This phenomenological study was led by a community-based organization. We conducted six focus groups with 53 BMSM living with HIV in Los Angeles. We used minority stress theory in the analysis and interpretation of the data. We identified two themes: (1) co-occurrence of race and sexual orientation stressors and smoking (e.g., "I feel like I'd be discriminated against sometimes because I'm gay and because I'm Black.") and (2) smoking as a reaction to HIV-positive status (e.g., "I know more people that started smoking after they found out they [had] HIV."). Participants smoked...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8qw107sx</guid>
      <pubDate>Wed, 27 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>del Pino, Homero E</name>
      </author>
      <author>
        <name>Dacus, Jagadisa-devasri</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>McWells, Charles</name>
      </author>
    </item>
    <item>
      <title>Socio-Structural and Neighborhood Predictors of Incident Criminal Justice Involvement in a Population-Based Cohort of Young Black MSM and Transgender Women</title>
      <link>https://escholarship.org/uc/item/782382wf</link>
      <description>Black men who have sex with men (MSM) and transgender women are disproportionately affected by criminal justice involvement (CJI) and HIV. This study recruited 618 young Black MSM and transgender women in Chicago, IL, using respondent-driven sampling between 2013 and 2014. Random effects logistic regression evaluated predictors of incident CJI over 18&amp;nbsp;months of follow-up. Controlling for respondent age, gender and sexual identity, spirituality (aOR 0.56, 95% CI 0.33-0.96), and presence of a mother figure (aOR 0.41, 95% CI 0.19-0.89) were protective against CJI. Economic hardship (financial or residential instability vs. neither aOR 2.23, 95% CI 1.10-4.51), two or more past episodes of CJI vs. none (aOR 2.66, 95% CI 1.40-5.66), and substance use (marijuana use vs. none aOR 2.79, 95% CI 1.23-6.34; other drug use vs. none aOR 4.49, 95% CI 1.66-12.16) were associated with CJI during follow-up. Research to identify and leverage resilience factors that can buffer the effects of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/782382wf</guid>
      <pubDate>Wed, 27 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Hotton, Anna L</name>
      </author>
      <author>
        <name>Chen, Yen-Tyng</name>
      </author>
      <author>
        <name>Schumm, Phil</name>
      </author>
      <author>
        <name>Khanna, Aditya S</name>
      </author>
      <author>
        <name>Brewer, Russell</name>
      </author>
      <author>
        <name>Skaathun, Britt</name>
      </author>
      <author>
        <name>Issema, Rodal S</name>
      </author>
      <author>
        <name>Ramani, Santhoshini</name>
      </author>
      <author>
        <name>Ramachandran, Arthi</name>
      </author>
      <author>
        <name>Ozik, Jonathan</name>
      </author>
      <author>
        <name>Fujimoto, Kayo</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Schneider, John A</name>
      </author>
    </item>
    <item>
      <title>Disparities In Uptake Of HIV Pre-Exposure Prophylaxis Among California Medicaid Enrollees</title>
      <link>https://escholarship.org/uc/item/4sf93033</link>
      <description>One of the pillars of efforts in the US to curb HIV incidence is pre-exposure prophylaxis (PrEP). We examined racial/ethnic and sex disparities in PrEP uptake among California Medicaid enrollees. Claims data from 2019 identified enrollees and PrEP users in each racial/ethnic, sex, and age group, yielding crude uptake rates. We then predicted age-adjusted uptake rates from multivariable logit regressions and divided PrEP uptake estimates by each group's number of new HIV diagnoses to estimate PrEP-to-need ratios. Predicted uptake was highest for White (0.29&amp;nbsp;percent) and Black (0.23&amp;nbsp;percent) males and lowest (0.16&amp;nbsp;percent) for Hispanic males. Rates for males exceeded those for females; however, Black females had twice the rate of PrEP uptake of White females. Black males and females and Hispanic males had PrEP-to-need ratios that were less than one-third (4.0-6.3) those of Asian and White males and females (14.4-19.9). Low PrEP use rates and disparities in uptake...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4sf93033</guid>
      <pubDate>Wed, 27 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Tan, Diane</name>
      </author>
      <author>
        <name>Leibowitz, Arleen A</name>
        <uri>https://orcid.org/0000-0001-6970-0564</uri>
      </author>
    </item>
    <item>
      <title>Hypoxia Is a Dominant Remodeler of the Effector T&amp;nbsp;Cell Surface Proteome Relative to Activation and Regulatory T Cell Suppression</title>
      <link>https://escholarship.org/uc/item/9232833z</link>
      <description>Immunosuppressive factors in the tumor microenvironment (TME) impair T cell function and limit the antitumor immune response. T cell surface receptors and surface proteins that influence interactions and function in the TME are proven targets for cancer immunotherapy. However, how the entire surface proteome remodels in primary human T cells in response to specific suppressive factors in the TME remains to be broadly and systematically characterized. Here, using a reductionist cell culture approach with primary human T cells and stable isotopic labeling with amino acids in cell culture-based quantitative cell surface capture glycoproteomics, we examined how two immunosuppressive TME factors, regulatory T cells (Tregs) and hypoxia, globally affect the activated CD8&lt;sup&gt;+&lt;/sup&gt; surface proteome (surfaceome). Surprisingly, coculturing primary CD8&lt;sup&gt;+&lt;/sup&gt; T cells with Tregs only modestly affected the CD8&lt;sup&gt;+&lt;/sup&gt; surfaceome but did partially reverse activation-induced surfaceomic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9232833z</guid>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Byrnes, James R</name>
      </author>
      <author>
        <name>Weeks, Amy M</name>
      </author>
      <author>
        <name>Shifrut, Eric</name>
      </author>
      <author>
        <name>Carnevale, Julia</name>
      </author>
      <author>
        <name>Kirkemo, Lisa</name>
      </author>
      <author>
        <name>Ashworth, Alan</name>
      </author>
      <author>
        <name>Marson, Alexander</name>
        <uri>https://orcid.org/0000-0002-2734-5776</uri>
      </author>
      <author>
        <name>Wells, James A</name>
      </author>
    </item>
    <item>
      <title>CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells</title>
      <link>https://escholarship.org/uc/item/87j6t6zg</link>
      <description>DNA nanostructures are a promising tool to deliver molecular payloads to cells. DNA origami structures, where long single-stranded DNA is folded into a compact nanostructure, present an attractive approach to package genes; however, effective delivery of genetic material into cell nuclei has remained a critical challenge. Here, we describe the use of DNA nanostructures encoding an intact human gene and a fluorescent protein encoding gene as compact templates for gene integration by CRISPR-mediated homology-directed repair (HDR). Our design includes CRISPR-Cas9 ribonucleoprotein binding sites on DNA nanostructures to increase shuttling into the nucleus. We demonstrate efficient shuttling and genomic integration of DNA nanostructures using transfection and electroporation. These nanostructured templates display lower toxicity and higher insertion efficiency compared to unstructured double-stranded DNA templates in human primary cells. Furthermore, our study validates virus-like...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/87j6t6zg</guid>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Lin-Shiao, Enrique</name>
      </author>
      <author>
        <name>Pfeifer, Wolfgang G</name>
      </author>
      <author>
        <name>Shy, Brian R</name>
      </author>
      <author>
        <name>Saffari Doost, Mohammad</name>
      </author>
      <author>
        <name>Chen, Evelyn</name>
      </author>
      <author>
        <name>Vykunta, Vivasvan S</name>
        <uri>https://orcid.org/0000-0002-5409-8635</uri>
      </author>
      <author>
        <name>Hamilton, Jennifer R</name>
      </author>
      <author>
        <name>Stahl, Elizabeth C</name>
      </author>
      <author>
        <name>Lopez, Diana M</name>
      </author>
      <author>
        <name>Sandoval Espinoza, Cindy R</name>
      </author>
      <author>
        <name>Deyanov, Alexander E</name>
      </author>
      <author>
        <name>Lew, Rachel J</name>
      </author>
      <author>
        <name>Poirer, Michael G</name>
      </author>
      <author>
        <name>Marson, Alexander</name>
        <uri>https://orcid.org/0000-0002-2734-5776</uri>
      </author>
      <author>
        <name>Castro, Carlos E</name>
      </author>
      <author>
        <name>Doudna, Jennifer A</name>
      </author>
    </item>
    <item>
      <title>Polygenic burden in focal and generalized epilepsies</title>
      <link>https://escholarship.org/uc/item/8056692p</link>
      <description>Rare genetic variants can cause epilepsy, and genetic testing has been widely adopted for severe, paediatric-onset epilepsies. The phenotypic consequences of common genetic risk burden for epilepsies and their potential future clinical applications have not yet been determined. Using polygenic risk scores (PRS) from a European-ancestry genome-wide association study in generalized and focal epilepsy, we quantified common genetic burden in patients with generalized epilepsy (GE-PRS) or focal epilepsy (FE-PRS) from two independent non-Finnish European cohorts (Epi25 Consortium, n = 5705; Cleveland Clinic Epilepsy Center, n = 620; both compared to 20 435 controls). One Finnish-ancestry population isolate (Finnish-ancestry Epi25, n = 449; compared to 1559 controls), two European-ancestry biobanks (UK Biobank, n = 383 656; Vanderbilt biorepository, n = 49 494), and one Japanese-ancestry biobank (BioBank Japan, n = 168 680) were used for additional replications. Across 8386 patients...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8056692p</guid>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Leu, Costin</name>
      </author>
      <author>
        <name>Stevelink, Remi</name>
      </author>
      <author>
        <name>Smith, Alexander W</name>
      </author>
      <author>
        <name>Goleva, Slavina B</name>
      </author>
      <author>
        <name>Kanai, Masahiro</name>
      </author>
      <author>
        <name>Ferguson, Lisa</name>
      </author>
      <author>
        <name>Campbell, Ciaran</name>
      </author>
      <author>
        <name>Kamatani, Yoichiro</name>
      </author>
      <author>
        <name>Okada, Yukinori</name>
      </author>
      <author>
        <name>Sisodiya, Sanjay M</name>
      </author>
      <author>
        <name>Cavalleri, Gianpiero L</name>
      </author>
      <author>
        <name>Koeleman, Bobby PC</name>
      </author>
      <author>
        <name>Lerche, Holger</name>
      </author>
      <author>
        <name>Jehi, Lara</name>
      </author>
      <author>
        <name>Davis, Lea K</name>
      </author>
      <author>
        <name>Najm, Imad M</name>
      </author>
      <author>
        <name>Palotie, Aarno</name>
      </author>
      <author>
        <name>Daly, Mark J</name>
      </author>
      <author>
        <name>Busch, Robyn M</name>
      </author>
      <author>
        <name>Consortium, Epi25</name>
      </author>
      <author>
        <name>Lal, Dennis</name>
      </author>
    </item>
    <item>
      <title>Opportunities and challenges for the development of “core outcome sets” in neuro-oncology</title>
      <link>https://escholarship.org/uc/item/1hn2z6n0</link>
      <description>Core Outcome Sets (COS) define minimum outcomes to be measured and reported in clinical effectiveness trials for a particular health condition/health area. Despite recognition as critical to clinical research design for other health areas, none have been developed for neuro-oncology. COS development projects should carefully consider: scope (how the COS should be used), stakeholders involved in development (including patients as both research partners and participants), and consensus methodologies used (typically a Delphi survey and consensus meeting), as well as dissemination plans. Developing COS for neuro-oncology is potentially challenging due to extensive tumor subclassification (including molecular stratification), different symptoms related to anatomical tumor location, and variation in treatment options. Development of a COS specific to tumor subtype, in a specific location, for a particular intervention may be too narrow and would be unlikely to be used. Equally, a COS...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1hn2z6n0</guid>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Millward, Christopher P</name>
      </author>
      <author>
        <name>Armstrong, Terri S</name>
      </author>
      <author>
        <name>Barrington, Heather</name>
      </author>
      <author>
        <name>Brodbelt, Andrew R</name>
      </author>
      <author>
        <name>Bulbeck, Helen</name>
      </author>
      <author>
        <name>Byrne, Anthony</name>
      </author>
      <author>
        <name>Dirven, Linda</name>
      </author>
      <author>
        <name>Gamble, Carrol</name>
      </author>
      <author>
        <name>Grundy, Paul L</name>
      </author>
      <author>
        <name>Islim, Abdurrahman I</name>
      </author>
      <author>
        <name>Javadpour, Mohsen</name>
      </author>
      <author>
        <name>Keshwara, Sumirat M</name>
      </author>
      <author>
        <name>Krishna, Sandhya T</name>
      </author>
      <author>
        <name>Mallucci, Conor L</name>
      </author>
      <author>
        <name>Marson, Anthony G</name>
        <uri>https://orcid.org/0000-0002-2734-5776</uri>
      </author>
      <author>
        <name>McDermott, Michael W</name>
        <uri>https://orcid.org/0000-0002-0682-6853</uri>
      </author>
      <author>
        <name>Meling, Torstein R</name>
      </author>
      <author>
        <name>Oliver, Kathy</name>
      </author>
      <author>
        <name>Pizer, Barry</name>
      </author>
      <author>
        <name>Plaha, Puneet</name>
      </author>
      <author>
        <name>Preusser, Matthias</name>
      </author>
      <author>
        <name>Santarius, Thomas</name>
      </author>
      <author>
        <name>Srikandarajah, Nisaharan</name>
      </author>
      <author>
        <name>Taphoorn, Martin JB</name>
      </author>
      <author>
        <name>Watts, Colin</name>
      </author>
      <author>
        <name>Weller, Michael</name>
      </author>
      <author>
        <name>Williamson, Paula R</name>
      </author>
      <author>
        <name>Zadeh, Gelareh</name>
      </author>
      <author>
        <name>Najafabadi, Amir H Zamanipoor</name>
      </author>
      <author>
        <name>Jenkinson, Michael D</name>
      </author>
    </item>
    <item>
      <title>Robust T cell activation requires an eIF3-driven burst in T cell receptor translation</title>
      <link>https://escholarship.org/uc/item/19j6w3pc</link>
      <description>Activation of T cells requires a rapid surge in cellular protein synthesis. However, the role of translation initiation in the early induction of specific genes remains unclear. Here, we show human translation initiation factor eIF3 interacts with select immune system related mRNAs including those encoding the T cell receptor (TCR) subunits TCRA and TCRB. Binding of eIF3 to the &lt;i&gt;TCRA&lt;/i&gt; and &lt;i&gt;TCRB&lt;/i&gt; mRNA 3'-untranslated regions (3'-UTRs) depends on CD28 coreceptor signaling and regulates a burst in TCR translation required for robust T cell activation. Use of the &lt;i&gt;TCRA&lt;/i&gt; or &lt;i&gt;TCRB&lt;/i&gt; 3'-UTRs to control expression of an anti-CD19 chimeric antigen receptor (CAR) improves the ability of CAR-T cells to kill tumor cells in vitro. These results identify a new mechanism of eIF3-mediated translation control that can aid T cell engineering for immunotherapy applications.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/19j6w3pc</guid>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <author>
        <name>De Silva, Dasmanthie</name>
      </author>
      <author>
        <name>Ferguson, Lucas</name>
      </author>
      <author>
        <name>Chin, Grant H</name>
      </author>
      <author>
        <name>Smith, Benjamin E</name>
      </author>
      <author>
        <name>Apathy, Ryan A</name>
      </author>
      <author>
        <name>Roth, Theodore L</name>
      </author>
      <author>
        <name>Blaeschke, Franziska</name>
      </author>
      <author>
        <name>Kudla, Marek</name>
      </author>
      <author>
        <name>Marson, Alexander</name>
        <uri>https://orcid.org/0000-0002-2734-5776</uri>
      </author>
      <author>
        <name>Ingolia, Nicholas T</name>
      </author>
      <author>
        <name>Cate, Jamie HD</name>
      </author>
    </item>
    <item>
      <title>Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California</title>
      <link>https://escholarship.org/uc/item/8sw1d8km</link>
      <description>BACKGROUND: TRIUMPH (Trans Research-Informed communities United in Mobilization for the Prevention of HIV) was a community-led, transgender-specific pre-exposure prophylaxis (PrEP) demonstration project at 2 community-based clinical sites in California. TRIUMPH used peer health education, community mobilization, and clinical integration of PrEP with hormone therapy to promote PrEP knowledge and acceptability. The goal of this study was to evaluate PrEP uptake, retention, and adherence among TRIUMPH participants and examine site-based differences.
METHODS: Eligible participants were adult transgender and gender diverse people interested in PrEP. Participants were seen at baseline and at 1, 3, 6, 9, and 12 months for PrEP provision, clinical visits, and HIV testing. PrEP uptake was defined as dispensation of PrEP, PrEP retention was defined as proportion of expected visits completed among those who initiated PrEP, and PrEP adherence was assessed by measuring tenofovir diphosphate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8sw1d8km</guid>
      <pubDate>Mon, 28 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Sevelius, Jae M</name>
      </author>
      <author>
        <name>Glidden, David V</name>
        <uri>https://orcid.org/0000-0001-5888-1419</uri>
      </author>
      <author>
        <name>Deutsch, Madeline</name>
      </author>
      <author>
        <name>Welborn, Layla</name>
      </author>
      <author>
        <name>Contreras, Alejandro</name>
      </author>
      <author>
        <name>Salinas, Arianna</name>
      </author>
      <author>
        <name>Venegas, Luz</name>
      </author>
      <author>
        <name>Grant, Robert M</name>
      </author>
    </item>
    <item>
      <title>Factors predicting incarceration history and incidence among Black and Latino men who have sex with men (MSM) residing in a major urban center</title>
      <link>https://escholarship.org/uc/item/7gj1986p</link>
      <description>We analyzed data from a cohort of Black and Latino men who have sex with men (MSM) in order to identify correlates of prevalent and incident incarceration, including potential predictors related to their status as sexual and gender minorities (SGMs). Baseline and follow-up self-administered survey data were examined from Los Angeles County participants' ages 18-45 years at enrollment who were either HIV negative or living with HIV, but recruited to over represent men who used drugs and men with unsuppressed HIV infection. Multivariable logistic regression models were developed to identify predictors of baseline incarceration history and of incident incarceration over study follow-up among 440 and 338 participants, respectively. Older age, Black race, low socioeconomic status, homelessness, stimulant use, and depression symptoms were associated with baseline incarceration history. The only SGM-related factor associated with baseline incarceration history was having experienced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7gj1986p</guid>
      <pubDate>Mon, 28 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Schrode, Katrina M</name>
      </author>
      <author>
        <name>Daniels, Joseph</name>
      </author>
      <author>
        <name>Javanbakht, Marjan</name>
        <uri>https://orcid.org/0000-0003-0088-3803</uri>
      </author>
      <author>
        <name>Hotton, Anna</name>
      </author>
      <author>
        <name>Makgoeng, Solomon</name>
      </author>
      <author>
        <name>Ragsdale, Amy</name>
      </author>
      <author>
        <name>Schneider, John</name>
      </author>
      <author>
        <name>Fujimoto, Kayo</name>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Gorbach, Pamina</name>
        <uri>https://orcid.org/0000-0003-2100-7765</uri>
      </author>
    </item>
    <item>
      <title>Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project</title>
      <link>https://escholarship.org/uc/item/36z6264b</link>
      <description>Little information is known about the cisgender women who seek and initiate pre-exposure prophylaxis (PrEP) for HIV prevention in the United States. Adherence Enhancement Guided by Individualized Texting and Drug Levels was a 48-week single-arm open-label demonstration study of daily oral tenofovir disoproxil fumaratel emtricitabine (TDF/FTC) in cisgender women ≥ 18 years old at risk for HIV. Participants were surveyed at screening and enrollment about sociodemographics, HIV risk perception and behaviors, and PrEP perspectives and aggregated into three risk groups according to HIV sexual risk behavior: being in a serodiscordant partnership (SD), engaging in sex work (SW), and having partners with unknown HIV status at risk for HIV (UP). One hundred sixty-seven women presented for screening with &lt;i&gt;n&lt;/i&gt; = 31 screen failures. Of the 162 women completing enrollment, mean age was 40 (standard deviation 11), with 41% non-Hispanic Black, 22% non-Hispanic White, and 19% Latina. Compared...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/36z6264b</guid>
      <pubDate>Mon, 28 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Landovitz, Raphael</name>
      </author>
      <author>
        <name>Jain, Sonia</name>
      </author>
      <author>
        <name>He, Feng</name>
      </author>
      <author>
        <name>Kofron, Ryan</name>
      </author>
      <author>
        <name>Ellorin, Eric</name>
      </author>
      <author>
        <name>Ntim, Gifty M</name>
      </author>
      <author>
        <name>Stockman, Jamila K</name>
      </author>
      <author>
        <name>Corado, Katya</name>
      </author>
      <author>
        <name>Amico, K Rivet</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
    </item>
    <item>
      <title>Sexually transmitted infections among participants in an HIV PrEP adherence trial</title>
      <link>https://escholarship.org/uc/item/0kd2f0mq</link>
      <description>BACKGROUND: HIV PrEP effectiveness is highly dependent on adherence. High STI incidence has been reported among PrEP users. We assessed the relationship between STI incidence (CT, NG, and syphilis) and PrEP adherence.
METHODS: We performed a subanalysis of a controlled, open-label, two-arm, randomized clinical demonstration project of a text-message based adherence intervention. Participants had 48&amp;nbsp;weeks of follow-up and had STI testing every 12 or 24&amp;nbsp;weeks. PrEP adherence was measured at week 48 using intracellular tenofovir-diphosphate drug concentrations. We calculated incidence rate ratios for STIs among those adherent as compared with those not adherent to PrEP.
RESULTS: Of the 381 assessed for CT, NG and syphilis at one or more follow-up visits, there were 16 cases of syphilis or 5.0 per 100 person years (95% CI: 2.6, 7.5); 63 cases of NG or 26.3 per 100 person years (95% CI: 19.8, 32.8); and 81 cases of CT or 36.3 per 100 person years (95% CI: 28.4, 44.2). We...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0kd2f0mq</guid>
      <pubDate>Thu, 17 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Bristow, Claire C</name>
      </author>
      <author>
        <name>Hassan, Adiba</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Dubé, Michael P</name>
      </author>
      <author>
        <name>Corado, Katya</name>
      </author>
      <author>
        <name>Chow, Karen</name>
      </author>
      <author>
        <name>Ellorin, Eric</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Morris, Sheldon R</name>
      </author>
      <author>
        <name>Team, The CCTG</name>
      </author>
    </item>
    <item>
      <title>Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California</title>
      <link>https://escholarship.org/uc/item/84c8301t</link>
      <description>As overdose mortality is spiking during the COVID-19 pandemic, few race/ethnicity-stratified trends are available. This is of particular concern as overdose mortality was increasing most rapidly in Black and Latinx communities prior to the pandemic. We used quarterly, age-standardized overdose mortality rates from California to assess trends by race/ethnicity and drug involved over time. Rates from 2020 Q2-Q4 were compared to expected trends based on ARIMA forecasting models fit using data from 2006 to 2020 Q1. In 2020 Q2-Q4 overdose death rates rose by 49.8% from 2019, exceeding an expected increase of 11.5% (95%CI: 0.5%-22.5%). Rates significantly exceeded forecasted trends for all racial/ethnic groups. Black/African American individuals saw an increase of 52.4% from 2019, compared to 42.6% among their White counterparts. The absolute Black-White overdose mortality gap rose from 0.7 higher per 100,000 for Black individuals in 2018 to 4.8 in 2019, and further increased to 9.9...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/84c8301t</guid>
      <pubDate>Mon, 14 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Friedman, Joseph</name>
      </author>
      <author>
        <name>Hansen, Helena</name>
      </author>
      <author>
        <name>Bluthenthal, Ricky N</name>
      </author>
      <author>
        <name>Harawa, Nina</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Jordan, Ayana</name>
      </author>
      <author>
        <name>Beletsky, Leo</name>
      </author>
    </item>
    <item>
      <title>A Systematic Review up to 2018 of HIV and Associated Factors Among Criminal Justice–Involved (CJI) Black Sexual and Gender Minority Populations in the United States (US)</title>
      <link>https://escholarship.org/uc/item/5nt5s143</link>
      <description>Black men who have sex with men (BMSM) and Black transgender women (BTW) are impacted by dual epidemics of HIV and incarceration. We advanced understanding of the relationship between criminal justice involvement, HIV, and other key HIV-related characteristics among these key populations in the US. We conducted a systematic review up to 2018 and 47 articles met the inclusion criteria of scientific publications involving quantitative findings of US-based HIV-related studies focused on criminal justice–involved (CJI) BMSM and BTW. Overall, there was a dearth of studies focused specifically on BTW. Criminal justice involvement was relatively high among BMSM and BTW and more pronounced among BTW. The current evidence favors no association between incarceration and HIV acquisition among BMSM with limited information about BTW. Criminal justice involvement was associated with a greater likelihood of STIs among BMSM with mixed results for sexual risk behaviors. Criminal justice settings...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5nt5s143</guid>
      <pubDate>Mon, 14 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Brewer, Russell</name>
      </author>
      <author>
        <name>Ramani, Santhoshini L</name>
      </author>
      <author>
        <name>Khanna, Aditya</name>
      </author>
      <author>
        <name>Fujimoto, Kayo</name>
      </author>
      <author>
        <name>Schneider, John A</name>
      </author>
      <author>
        <name>Hotton, Anna</name>
      </author>
      <author>
        <name>Wilton, Leo</name>
      </author>
      <author>
        <name>Escobedo, Tania</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Mobile-Enhanced Prevention Support Study for Men Who Have Sex With Men and Transgender Women Leaving Jail: Protocol for a Randomized Controlled Trial</title>
      <link>https://escholarship.org/uc/item/8440t2ps</link>
      <description>BACKGROUND: Men who have sex with men (MSM) and transgender women, particularly those who have experienced criminal justice involvement, have particularly high HIV burdens, and a majority of those in jail have substance use disorders (SUDs). MSM and transgender women also experience elevated rates of incarceration. Once community re-entry occurs, individuals are in a critical period for addressing potential risks of HIV and sexually transmitted infection (STI) acquisition and negative sequelae of substance use. Further, the impact experienced by one's social and sexual networks experienced at the time of detention and release have important health implications for MSM and transgender women.
OBJECTIVE: The purpose of this study is to test a new intervention-Mobile-Enhanced Prevention Support (MEPS)-that involves a GPS-based mobile app called GeoPassport (referred to as GeoPass in practice), incentives, and peer support for promoting HIV prevention, substance use treatment, and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8440t2ps</guid>
      <pubDate>Mon, 7 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Edwards, Gabriel G</name>
        <uri>https://orcid.org/0000-0002-1083-0919</uri>
      </author>
      <author>
        <name>Reback, Cathy J</name>
      </author>
      <author>
        <name>Cunningham, William E</name>
      </author>
      <author>
        <name>Hilliard, Charles L</name>
      </author>
      <author>
        <name>McWells, Charles</name>
      </author>
      <author>
        <name>Mukherjee, Sukrit</name>
      </author>
      <author>
        <name>Weiss, Robert E</name>
        <uri>https://orcid.org/0000-0003-3648-8522</uri>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>Small Randomized Controlled Trial of the New Passport to Wellness HIV Prevention Intervention for Black Men Who Have Sex with Men (BMSM)</title>
      <link>https://escholarship.org/uc/item/1373904v</link>
      <description>We developed and tested Passport to Wellness (PtW), a client-centered intervention to improve engagement in HIV/STI prevention and services to improve social determinants of health among Black men who have sex with men (BMSM) using incentives and peer support. We assessed PtW's impact on HIV/STI screening and pre/post-exposure prophylaxis (PrEP/PEP) knowledge/uptake using a randomized trial that compared the full intervention to one lacking peer support. We compared changes within groups surveyed at baseline and 6 months. We enrolled 80 eligible BMSM, among 399 screened. Among retained participants (34 peer-supported; 27 comparison), overall increases were observed in HIV (30% to 87%; &lt;i&gt;p&lt;/i&gt; &amp;lt; .001) and STI (28% to 80%; &lt;i&gt;p&lt;/i&gt; &amp;lt; .001) testing within the prior 6 months, as well as in PrEP and PEP awareness, and PrEP use. Statistically significant between group differences were not observed. Tailored prevention planning, incentives, and addressing social determinants may...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1373904v</guid>
      <pubDate>Mon, 7 Mar 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
      <author>
        <name>Schrode, Katrina M</name>
      </author>
      <author>
        <name>McWells, Charles</name>
      </author>
      <author>
        <name>Weiss, Robert E</name>
        <uri>https://orcid.org/0000-0003-3648-8522</uri>
      </author>
      <author>
        <name>Hilliard, Charles L</name>
      </author>
      <author>
        <name>Bluthenthal, Ricky N</name>
        <uri>https://orcid.org/0000-0003-3491-1702</uri>
      </author>
    </item>
    <item>
      <title>ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV</title>
      <link>https://escholarship.org/uc/item/7vq4m8wm</link>
      <description>OBJECTIVE: We investigated whether apolipoprotein A-I (apoA-I) mimetic peptides 4F and 6F can be a novel therapeutic strategy to reduce blood and gut bioactive lipids, proinflammatory effects of endotoxin (LPS) and aberrant activation of cyclooxygenase 2 (COX-2) as instigators of increased risk for cardiometabolic disease in chronic treated HIV.
METHODS: We used two humanized murine models of chronic treated HIV infection (n = 109 mice) and gut explants from HIV infected (n = 10) persons to determine whether Tg6F and 4F attenuate in vivo and ex vivo increased blood and gut bioactive lipids (measured by mass spectrometry) and intestinal protein levels of COX-2 (measured by immunoassays) in chronic treated HIV.
RESULTS: In these models of HIV, when compared to HIV-1 infected mice on antiretroviral therapy (ART) alone, oral Tg6F in combination with ART attenuated increases in plasma and gut bioactive lipids (and particularly COX lipids) and intestinal COX-2. 4F and Tg6F also reduced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7vq4m8wm</guid>
      <pubDate>Mon, 7 Feb 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Daskou, M</name>
      </author>
      <author>
        <name>Sharma, M</name>
      </author>
      <author>
        <name>Mu, W</name>
      </author>
      <author>
        <name>Heymans, R</name>
      </author>
      <author>
        <name>Ritou, E</name>
      </author>
      <author>
        <name>Rezek, V</name>
      </author>
      <author>
        <name>Hamid, P</name>
      </author>
      <author>
        <name>Kossyvakis, A</name>
      </author>
      <author>
        <name>Roy, S Sen</name>
      </author>
      <author>
        <name>Grijalva, V</name>
      </author>
      <author>
        <name>Chattopadhyay, A</name>
      </author>
      <author>
        <name>Papesh, J</name>
      </author>
      <author>
        <name>Meriwether, D</name>
      </author>
      <author>
        <name>Kitchen, SG</name>
      </author>
      <author>
        <name>Fogelman, AM</name>
      </author>
      <author>
        <name>Reddy, ST</name>
      </author>
      <author>
        <name>Kelesidis, T</name>
        <uri>https://orcid.org/0000-0002-8463-3811</uri>
      </author>
    </item>
    <item>
      <title>Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP</title>
      <link>https://escholarship.org/uc/item/5563s0j5</link>
      <description>BACKGROUND: We evaluated the association of inflammation and dysbosis on cervicovaginal fluid (CVF) tenofovir (TFV) concentrations in women taking oral tenofovir disoproxil fumarate/emtricitable for HIV pre-exposure prophylaxis (PrEP) in the United States.
SETTING: Thirty-five women in a HIV PrEP implementation study attended their week 24 visit at a San Diego research clinic and provided CVF specimens.
METHODS: Women in the Adherence Enhancement Guided by Individualized Texting and Drug Levels study had their CVF specimens evaluated for (1) sexually transmitted bacterial (Neisseria gonorrhoeae, Chlamydia trachomatis, Gardnerella, and Trichomonas vaginalis), viral (human papillomavirus, cytomegalovirus and herpes simplex virus-1/2) and fungal (Candida) infections; (2) microbiome composition by 16 S sequencing (V3-V4 region); and (3) cytokine profiles by enzyme-linked immunoassay (Interleukin-8, macrophage Inflammatory protein-1a, macrophage Inflammatory Protein-1b and interferon-γ-inducible...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5563s0j5</guid>
      <pubDate>Thu, 3 Feb 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Cottrell, Mackenzie</name>
      </author>
      <author>
        <name>Rawlings, Stephen A</name>
      </author>
      <author>
        <name>Peterson, Scott</name>
      </author>
      <author>
        <name>Karris, Maile</name>
      </author>
      <author>
        <name>Pacheco, Deedee</name>
      </author>
      <author>
        <name>Chaillon, Antoine</name>
        <uri>https://orcid.org/0000-0001-9490-3857</uri>
      </author>
      <author>
        <name>Kay, Alexis</name>
      </author>
      <author>
        <name>Chow, Karen</name>
      </author>
      <author>
        <name>Anderson, Peter L</name>
      </author>
      <author>
        <name>Gianella, Sara</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
    </item>
    <item>
      <title>ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV</title>
      <link>https://escholarship.org/uc/item/9p31s6dn</link>
      <description>Novel therapeutic strategies are needed to attenuate increased systemic and gut inflammation that contribute to morbidity and mortality in chronic HIV infection despite potent antiretroviral therapy (ART). The goal of this study is to use preclinical models of chronic treated HIV to determine whether the antioxidant and anti-inflammatory apoA-I mimetic peptides 6F and 4F attenuate systemic and gut inflammation in chronic HIV. We used two humanized murine models of HIV infection and gut explants from 10 uninfected and 10 HIV infected persons on potent ART, to determine the in vivo and ex vivo impact of apoA-I mimetics on systemic and intestinal inflammation in HIV. When compared to HIV infected humanized mice treated with ART alone, mice on oral apoA-I mimetic peptide 6F with ART had consistently reduced plasma and gut tissue cytokines (TNF-α, IL-6) and chemokines (CX3CL1) that are products of ADAM17 sheddase activity. Oral 6F attenuated gut protein levels of ADAM17 that were increased...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9p31s6dn</guid>
      <pubDate>Mon, 17 Jan 2022 00:00:00 +0000</pubDate>
      <author>
        <name>Daskou, Maria</name>
      </author>
      <author>
        <name>Mu, William</name>
      </author>
      <author>
        <name>Sharma, Madhav</name>
      </author>
      <author>
        <name>Vasilopoulos, Hariclea</name>
      </author>
      <author>
        <name>Heymans, Rachel</name>
      </author>
      <author>
        <name>Ritou, Eleni</name>
      </author>
      <author>
        <name>Rezek, Valerie</name>
      </author>
      <author>
        <name>Hamid, Philip</name>
      </author>
      <author>
        <name>Kossyvakis, Athanasios</name>
      </author>
      <author>
        <name>Roy, Shubhendu Sen</name>
      </author>
      <author>
        <name>Grijalva, Victor</name>
      </author>
      <author>
        <name>Chattopadhyay, Arnab</name>
      </author>
      <author>
        <name>Kitchen, Scott G</name>
        <uri>https://orcid.org/0000-0001-6182-6082</uri>
      </author>
      <author>
        <name>Fogelman, Alan M</name>
      </author>
      <author>
        <name>Reddy, Srinivasa T</name>
      </author>
      <author>
        <name>Kelesidis, Theodoros</name>
        <uri>https://orcid.org/0000-0002-8463-3811</uri>
      </author>
    </item>
    <item>
      <title>HIV and syphilis testing preferences among men who have sex with men and among transgender women in Lima, Peru</title>
      <link>https://escholarship.org/uc/item/77f5t0qm</link>
      <description>BACKGROUND: Men who have sex with men (MSM) and transgender women in Peru are at high risk for acquiring syphilis and HIV infection. The World Health Organization highly recommends screening for HIV and syphilis to reduce morbidity and mortality associated with untreated infections. We aimed to identify factors associated with dual testing preferences for HIV and syphilis infection among MSM and transgender women in Lima, Peru.
METHODS: We used conjoint analysis, an innovative method for systematically estimating consumer preferences. We created eight hypothetical test profiles varying across six dichotomous attributes: cost (free vs. $4), potential for false positive syphilis result (no false positive vs. some risk of false positive), time-to-result (20 minutes vs. 1 week), blood draw method (finger prick vs. venipuncture), test type (rapid vs. laboratory), and number of draws (1 vs. 2). We fit a conjoint analysis model for each participant using a simple main effects ANOVA....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/77f5t0qm</guid>
      <pubDate>Mon, 20 Sep 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Bristow, Claire C</name>
      </author>
      <author>
        <name>Kojima, Noah</name>
        <uri>https://orcid.org/0000-0002-3667-9719</uri>
      </author>
      <author>
        <name>Lee, Sung-Jae</name>
        <uri>https://orcid.org/0000-0002-7924-7430</uri>
      </author>
      <author>
        <name>Leon, Segundo R</name>
      </author>
      <author>
        <name>Ramos, Lourdes B</name>
      </author>
      <author>
        <name>Konda, Kelika A</name>
      </author>
      <author>
        <name>Brown, Brandon</name>
        <uri>https://orcid.org/0000-0002-6348-4108</uri>
      </author>
      <author>
        <name>Caceres, Carlos F</name>
      </author>
      <author>
        <name>Klausner, Jeffrey D</name>
      </author>
    </item>
    <item>
      <title>Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV</title>
      <link>https://escholarship.org/uc/item/9dq02876</link>
      <description>&lt;b&gt;Background:&lt;/b&gt; Substance use and mental health are two barriers to engagement in care and antiretroviral therapy (ART) adherence among youth and young adults living with HIV (YLWH). The consequences of suboptimal adherence in YLWH are increased risk of HIV transmission and a future generation of immunodeficient adults with drug-resistant virus. &lt;b&gt;Methods:&lt;/b&gt; The Youth to Telehealth and Texting for Engagement in Care (Y2TEC) study was a pilot randomized crossover trial that examined the feasibility and acceptability of a novel video-counseling series and accompanying text messages aimed at mental health, substance use, and HIV care engagement for YLWH. The intervention consisted of twelve 20-30-min weekly video-counseling sessions focused on identifying and addressing barriers to HIV care, mental health, and substance use challenges. Participants completed quantitative surveys at baseline, 4 months, and 8 months. Feasibility and acceptability were evaluated using prespecified...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9dq02876</guid>
      <pubDate>Mon, 16 Aug 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Saberi, Parya</name>
        <uri>https://orcid.org/0000-0002-3793-5112</uri>
      </author>
      <author>
        <name>McCuistian, Caravella</name>
      </author>
      <author>
        <name>Agnew, Emily</name>
      </author>
      <author>
        <name>Wootton, Angie R</name>
      </author>
      <author>
        <name>Packard, Dominique A Legnitto</name>
      </author>
      <author>
        <name>Dawson-Rose, Carol</name>
        <uri>https://orcid.org/0000-0001-6066-1853</uri>
      </author>
      <author>
        <name>Johnson, Mallory O</name>
      </author>
      <author>
        <name>Gruber, Valerie A</name>
      </author>
      <author>
        <name>Neilands, Torsten B</name>
      </author>
    </item>
    <item>
      <title>Measuring Gender Role Conflict, Internalized Stigma, and Racial and Sexual Identity in Behaviorally Bisexual Black Men</title>
      <link>https://escholarship.org/uc/item/26t0k1qb</link>
      <description>Black men who have sex with men and women (BMSMW) experience pressure to fill hypermasculine ideals and may not identify with “gay” cultural norms. Existing measures of gender role expectations and internalized homophobia are not culturally appropriate for BMSMW. Researchers generally measure categorical identification with race, gender, and sexual orientation groups separately, whereas BMSMW may identify with multiple categories. We modified the Gender Role Conflict Scale to create the M-GRCS and the Internalized Homophobia Scale to include biphobia (Internalized Bi/Homophobia Scale, IBHS). To examine identification at the intersection of race, gender, and sexual orientation, we created 11 Integrated Race and Sexuality Scale (IRSS) items. With data from 429 BMSMW, we conducted exploratory factor analysis of the 59 items using categorical principal axis factoring with unweighted least squares extraction and Promax factor rotation. We created simple-summated multi-item scales and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/26t0k1qb</guid>
      <pubDate>Wed, 4 Aug 2021 00:00:00 +0000</pubDate>
      <author>
        <name>del Pino, Homero E</name>
      </author>
      <author>
        <name>Steers, W Neil</name>
      </author>
      <author>
        <name>Lee, Martin</name>
      </author>
      <author>
        <name>McCuller, Jason</name>
      </author>
      <author>
        <name>Hays, Ron D</name>
      </author>
      <author>
        <name>Harawa, Nina T</name>
        <uri>https://orcid.org/0000-0002-7486-8393</uri>
      </author>
    </item>
    <item>
      <title>HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy</title>
      <link>https://escholarship.org/uc/item/94f508p9</link>
      <description>Although current combinatorial antiretroviral therapy (cART) is therapeutically effective in the majority of HIV patients, interruption of therapy can cause a rapid rebound in viremia, demonstrating the existence of a stable reservoir of latently infected cells. HIV latency is therefore considered a primary barrier to HIV eradication. Identifying, quantifying, and purging the HIV reservoir is crucial to effectively curing patients and relieving them from the lifelong requirement for therapy. Latently infected transformed cell models have been used to investigate HIV latency; however, these models cannot accurately represent the quiescent cellular environment of primary latently infected cells &lt;i&gt;in vivo&lt;/i&gt; For this reason, &lt;i&gt;in vivo&lt;/i&gt; humanized murine models have been developed for screening antiviral agents, identifying latently infected T cells, and establishing treatment approaches for HIV research. Such models include humanized bone marrow/liver/thymus mice and SCID-hu-thy/liv...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/94f508p9</guid>
      <pubDate>Wed, 14 Jul 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Satheesan, Sangeetha</name>
      </author>
      <author>
        <name>Li, Haitang</name>
      </author>
      <author>
        <name>Burnett, John C</name>
        <uri>https://orcid.org/0000-0002-8817-6064</uri>
      </author>
      <author>
        <name>Takahashi, Mayumi</name>
      </author>
      <author>
        <name>Li, Shasha</name>
      </author>
      <author>
        <name>Wu, Shiny Xiaqin</name>
      </author>
      <author>
        <name>Synold, Timothy W</name>
      </author>
      <author>
        <name>Rossi, John J</name>
      </author>
      <author>
        <name>Zhou, Jiehua</name>
      </author>
    </item>
    <item>
      <title>“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women</title>
      <link>https://escholarship.org/uc/item/23370815</link>
      <description>BackgroundPrior to implementing a pre-exposure prophylaxis (PrEP) demonstration study, we sought to explore cisgender women’s experiences with HIV prevention, PrEP knowledge and attitudes, and anticipated barriers and facilitators for PrEP uptake and adherence in Southern California.
MethodsThree focus groups were held with cisgender women of mixed HIV serostatus in San Diego and Los Angeles between November 2015 and January 2016. Women were recruited through local testing sites, community-based organizations, and social media. Focus groups were audio-recorded and transcripts were analyzed using thematic analysis.ResultsTwenty-two women participated in focus groups, with median age 44 (IQR 30–53) and 6 identifying as non-Hispanic Black, 7 non-Hispanic White, 8 Latina and 1 mixed race. Despite limited prior PrEP knowledge and no PrEP experience, participants expressed interest in taking PrEP. Anticipated benefits were freedom from worry about HIV and control over sexual health;...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/23370815</guid>
      <pubDate>Fri, 11 Jun 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Pasipanodya, Elizabeth C</name>
      </author>
      <author>
        <name>Stockman, Jamila</name>
      </author>
      <author>
        <name>Phuntsog, Thupten</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Psaros, Christina</name>
      </author>
      <author>
        <name>Landovitz, Raphael</name>
      </author>
      <author>
        <name>Amico, K Rivet</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
    </item>
    <item>
      <title>Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States</title>
      <link>https://escholarship.org/uc/item/7x58d3fc</link>
      <description>BACKGROUND: Daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) is effective for reducing human immunodeficiency virus (HIV) acquisition among cisgender women. We report results from the first US observational open-label demonstration project of pre-exposure prophylaxis (PrEP) among at-risk cisgender women.
METHODS: Adherence Enhancement Guided by Individualized Texting and Drug Levels was a 48-week, single-arm, open-label demonstration study of daily oral TDF/FTC in cisgender women ≥18 years old at risk for HIV. Adherence was supported using 2-way text messaging and titrated adherence counseling based on rapid-turnaround tenofovir diphosphate concentrations from dried blood spots. Study visits occurred at baseline, weeks 4 and 12, and quarterly through week 48. Outcomes included TDF/FTC adherence, retention, and persistence.
RESULTS: From June 2016 to October 2018, 136 cisgender women enrolled (mean age, 40 years (standard deviation, 11); 38% non-Hispanic Black and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7x58d3fc</guid>
      <pubDate>Wed, 12 May 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Jain, Sonia</name>
      </author>
      <author>
        <name>He, Feng</name>
      </author>
      <author>
        <name>Amico, K Rivet</name>
      </author>
      <author>
        <name>Kofron, Ryan</name>
      </author>
      <author>
        <name>Ellorin, Eric</name>
      </author>
      <author>
        <name>Stockman, Jamila K</name>
      </author>
      <author>
        <name>Psaros, Christina</name>
      </author>
      <author>
        <name>Ntim, Gifty M</name>
      </author>
      <author>
        <name>Chow, Karen</name>
      </author>
      <author>
        <name>Anderson, Peter L</name>
      </author>
      <author>
        <name>Haubrich, Richard</name>
      </author>
      <author>
        <name>Corado, Katya</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Landovitz, Raphael J</name>
      </author>
    </item>
    <item>
      <title>Methodological approaches for the prediction of opioid use-related epidemics in the United States: a narrative review and cross-disciplinary call to action</title>
      <link>https://escholarship.org/uc/item/1km9q504</link>
      <description>The opioid crisis in the United States has been defined by waves of drug- and locality-specific Opioid use-Related Epidemics (OREs) of overdose and bloodborne infections, among a range of health harms. The ability to identify localities at risk of such OREs, and better yet, to predict which ones will experience them, holds the potential to mitigate further morbidity and mortality. This narrative review was conducted to identify and describe quantitative approaches aimed at the "risk assessment," "detection" or "prediction" of OREs in the United States. We implemented a PubMed search composed of the: (1) objective (eg, prediction), (2) epidemiologic outcome (eg, outbreak), (3) underlying cause (ie, opioid use), (4) health outcome (eg, overdose, HIV), (5) location (ie, US). In total, 46 studies were included, and the following information extracted: discipline, objective, health outcome, drug/substance type, geographic region/unit of analysis, and data sources. Studies identified...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1km9q504</guid>
      <pubDate>Fri, 16 Apr 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Marks, Charles</name>
      </author>
      <author>
        <name>Carrasco-Escobar, Gabriel</name>
      </author>
      <author>
        <name>Carrasco-Hernández, Rocío</name>
      </author>
      <author>
        <name>Johnson, Derek</name>
      </author>
      <author>
        <name>Ciccarone, Dan</name>
        <uri>https://orcid.org/0000-0002-2355-5477</uri>
      </author>
      <author>
        <name>Strathdee, Steffanie A</name>
      </author>
      <author>
        <name>Smith, Davey</name>
        <uri>https://orcid.org/0000-0003-3603-1733</uri>
      </author>
      <author>
        <name>Bórquez, Annick</name>
      </author>
    </item>
    <item>
      <title>Barriers and facilitators to PrEP initiation and adherence among transgender and gender non-binary individuals in Southern California</title>
      <link>https://escholarship.org/uc/item/2vq7s0jf</link>
      <description>While transgender and gender non-binary (trans/nb) individuals are disproportionately affected by HIV, pre-exposure prophylaxis (PrEP) uptake remains low in this underserved population. We conducted four focus groups with 37 trans/nb individuals in San Diego and Los Angeles to assess barriers and facilitators of PrEP usage. Transcripts were coded for qualitative themes. Although overall PrEP awareness was high, participants reported limited knowledge and misinformation about PrEP. Barriers to PrEP use included: structural access (e.g., discrimination from health care providers, lack of trans-inclusive services, financial barriers), mental health struggles limiting ability to access PrEP, and concerns about potential side effects, drug-drug interactions with hormone therapy, and lack of other STI protection. Facilitators of PrEP usage included: increased PrEP availability, prior experience taking daily medications, and motivation to have active and healthy lives without fear of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2vq7s0jf</guid>
      <pubDate>Thu, 18 Mar 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Watson, C Wei-Ming</name>
      </author>
      <author>
        <name>Pasipanodya, Elizabeth</name>
      </author>
      <author>
        <name>Savin, Micah J</name>
      </author>
      <author>
        <name>Ellorin, Eric E</name>
      </author>
      <author>
        <name>Corado, Katya C</name>
      </author>
      <author>
        <name>Flynn, Risa P</name>
      </author>
      <author>
        <name>Opalo, Chloé</name>
      </author>
      <author>
        <name>Lampley, Elizabeth</name>
      </author>
      <author>
        <name>Henry, Brook L</name>
      </author>
      <author>
        <name>Blumenthal, Jill</name>
      </author>
      <author>
        <name>Bolan, Robert</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
      <author>
        <name>Moore, David J</name>
        <uri>https://orcid.org/0000-0002-2199-1662</uri>
      </author>
    </item>
    <item>
      <title>Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California</title>
      <link>https://escholarship.org/uc/item/1h37m6qx</link>
      <description>Black and Hispanic/Latinx transgender women in the United States (U.S.) are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) reduces risk of HIV infection but PrEP&amp;nbsp;uptake remains low among Black and Hispanic/Latinx transgender women. Between July 2018 and August 2019, we conducted individual interviews with 30 Black and Hispanic/Latinx transgender women who were prescribed PrEP through a PrEP demonstration project and 10 healthcare providers who provide PrEP services to transgender women in Los Angeles and San Diego, California. The interviews assessed general attitudes, experiences, and beliefs about PrEP as well as individual-, interpersonal-, community-, and structural-level barriers to PrEP&amp;nbsp;uptake and adherence. PrEP adherence was assessed by collecting quantitative intracellular tenofovir-diphosphate (TFV-DP) levels in retrospect on batched, banked dried blood spot (DBS) samples. We utilized qualitative content analysis to identify themes from...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1h37m6qx</guid>
      <pubDate>Wed, 17 Mar 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Ogunbajo, Adedotun</name>
      </author>
      <author>
        <name>Storholm, Erik D</name>
      </author>
      <author>
        <name>Ober, Allison J</name>
      </author>
      <author>
        <name>Bogart, Laura M</name>
      </author>
      <author>
        <name>Reback, Cathy J</name>
      </author>
      <author>
        <name>Flynn, Risa</name>
      </author>
      <author>
        <name>Lyman, Phoebe</name>
      </author>
      <author>
        <name>Morris, Sheldon</name>
      </author>
    </item>
    <item>
      <title>The UCSC SARS-CoV-2 Genome Browser</title>
      <link>https://escholarship.org/uc/item/1506p3q9</link>
      <description>The UCSC SARS-CoV-2 Genome Browser (https://genome.ucsc.edu/covid19.html) is an adaptation of our popular genome-browser visualization tool for this virus, containing many annotation tracks and new features, including conservation with similar viruses, immune epitopes, RT–PCR and sequencing primers and CRISPR guides. We invite all investigators to contribute to this resource to accelerate research and development activities globally.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1506p3q9</guid>
      <pubDate>Wed, 10 Mar 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Fernandes, Jason D</name>
      </author>
      <author>
        <name>Hinrichs, Angie S</name>
        <uri>https://orcid.org/0000-0002-1697-1130</uri>
      </author>
      <author>
        <name>Clawson, Hiram</name>
      </author>
      <author>
        <name>Gonzalez, Jairo Navarro</name>
      </author>
      <author>
        <name>Lee, Brian T</name>
        <uri>https://orcid.org/0000-0001-6382-9738</uri>
      </author>
      <author>
        <name>Nassar, Luis R</name>
        <uri>https://orcid.org/0000-0002-6706-2586</uri>
      </author>
      <author>
        <name>Raney, Brian J</name>
        <uri>https://orcid.org/0000-0002-9708-1390</uri>
      </author>
      <author>
        <name>Rosenbloom, Kate R</name>
      </author>
      <author>
        <name>Nerli, Santrupti</name>
      </author>
      <author>
        <name>Rao, Arjun A</name>
      </author>
      <author>
        <name>Schmelter, Daniel</name>
      </author>
      <author>
        <name>Fyfe, Alastair</name>
      </author>
      <author>
        <name>Maulding, Nathan</name>
      </author>
      <author>
        <name>Zweig, Ann S</name>
      </author>
      <author>
        <name>Lowe, Todd M</name>
      </author>
      <author>
        <name>Ares, Manuel</name>
        <uri>https://orcid.org/0000-0002-2552-9168</uri>
      </author>
      <author>
        <name>Corbet-Detig, Russ</name>
      </author>
      <author>
        <name>Kent, W James</name>
      </author>
      <author>
        <name>Haussler, David</name>
        <uri>https://orcid.org/0000-0003-1533-4575</uri>
      </author>
      <author>
        <name>Haeussler, Maximilian</name>
        <uri>https://orcid.org/0000-0001-8721-8253</uri>
      </author>
    </item>
    <item>
      <title>Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools</title>
      <link>https://escholarship.org/uc/item/7d06w40r</link>
      <description>Coronavirus disease 2019 (COVID-19) is a highly transmissible disease that has affected more than 90% of the countries worldwide. At least 17 million individuals have been infected, and some countries are still battling first or second waves of the pandemic. Nucleic acid tests, especially reverse transcription polymerase chain reaction (RT-PCR), have become the workhorse for early detection of COVID-19 infection. Positive controls for the molecular assays have been developed to validate each test and to provide high accuracy. However, most available positive controls require cold-chain distribution and cannot serve as full-process control. To overcome these shortcomings, we report the production of biomimetic virus-like particles (VLPs) as SARS-CoV-2 positive controls. A SARS-CoV-2 detection module for RT-PCR was encapsidated into VLPs from a bacteriophage and a plant virus. The chimeric VLPs were obtained either by &lt;i&gt;in vivo&lt;/i&gt; reconstitution and coexpression of the target...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7d06w40r</guid>
      <pubDate>Thu, 4 Mar 2021 00:00:00 +0000</pubDate>
      <author>
        <name>Chan, Soo Khim</name>
      </author>
      <author>
        <name>Du, Pinyi</name>
      </author>
      <author>
        <name>Ignacio, Caroline</name>
      </author>
      <author>
        <name>Mehta, Sanjay</name>
        <uri>https://orcid.org/0000-0002-2028-8158</uri>
      </author>
      <author>
        <name>Newton, Isabel G</name>
      </author>
      <author>
        <name>Steinmetz, Nicole F</name>
      </author>
    </item>
  </channel>
</rss>
